iodine I 131 monoclonal antibody CC49-deltaCH2


Recombinant Fowlpox-Prostate Specific Antigen Vaccine


Stage 4S neuroblastoma

biolink:Disease biolink:DiseaseOrPhenotypicFeature biolink:BiologicalEntity biolink:ThingWithTaxon biolink:NamedThing


Ataxia as late effect of cerebrovascular disease


Vertigo as late effect of cerebrovascular disease


Metastatic Esophageal Squamous Cell Carcinoma


Chronic lymphocytic leukaemia transformation


Glucose metabolism abnormal

biolink:PhenotypicFeature biolink:DiseaseOrPhenotypicFeature biolink:BiologicalEntity biolink:ThingWithTaxon biolink:NamedThing


Atrial fibrillation with rapid ventricular response


Bacteremia caused by Staphylococcus aureus


Primary human immunodeficiency virus infection


INJECTION, BUPRENORPHINE HYDROCHLORIDE, 0.1 MG ADMINISTERED


INJECTION, FONDAPARINUX SODIUM, 0.5 MG ADMINISTERED


INJECTION, IRON SUCROSE, 1 MG ADMINISTERED


INJECTION, TRIPTORELIN PAMOATE, 3.75 MG ADMINISTERED


Boric acidum, boric acid, Homeopathic preparation


Saccharum officinale, sucrose, cane sugar, Homeopathic preparation


Ferrum metallicum, Homeopathic preparation


Low Grade Prostatic Intraepithelial Neoplasia


Portia brand of ethinyl estradiol/levonorgestrel


Platinum metallicum, platinum, Homeopathic preparation


Natrium fluoratum, sodium fluoride, Homeopathic preparation


Natrium lacticum, Homeopathic preparation


Saccharum lactis, Homeopathic preparation


Carnitine deficiency due to hemodialysis


Peripartum cardiomyopathy, postpartum condition or complication


Diarrhea predominant irritable bowel syndrome


Indication for modification of patient status


Follicular non-Hodgkin's lymphoma, large cell


Traumatic brain injury with brief loss of consciousness


Gonadotropin releasing hormone antagonist


Diarrhea-associated hemolytic uremic syndrome


Recombinant human granulocyte colony stimulating factor


CD-30 positive pleomorphic large T-cell cutaneous lymphoma


CD-30 positive T-immunoblastic cutaneous lymphoma


Primary cutaneous diffuse large cell B-cell lymphoma


Follicular occlusion tetrad - hidradenitis, acne conglobata, dissecting cellulitis, pilonidal sinus


Acute non-ST segment elevation myocardial infarction (disorder)


Infectious disease of genitourinary system


Gastro-esophageal reflux disease with ulceration


Local recurrence of malignant tumor of breast


Inflammatory disorder of the respiratory tract


Urological system complication of procedure


Temporomandibular joint disc displacement


Temporomandibular joint disc displacement, with reduction


Inflammatory disorder of the cardiovascular system


Non-insulin-dependent diabetes mellitus with unspecified complications


Myelodysplastic syndrome with ring sideroblasts and multilineage dysplasia


Polymorphic lymphoproliferative disorder following transplant


Incomplete reversal of neuromuscular block


Complex atypical endometrial hyperplasia


Basal cell carcinoma in basal cell nevus syndrome


Low Grade Squamous Intraepithelial Neoplasia


Sclerodermoid chronic graft-versus-host disease


Oral mucosal disease due to graft-versus-host disease


Primary malignant neoplasm of hypopharynx


Family history of ischemic heart disease


INJECTION, ALEFACEPT, 0.5 MG ADMINISTERED


INJECTION, BIVALIRUDIN, 1 MG ADMINISTERED


INJECTION, MEROPENEM, 100 MG ADMINISTERED


INJECTION, RASBURICASE, 0.5 MG ADMINISTERED


INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


Pituitary Adenylate Cyclase Activating Polypeptide 38


Sertoli-Leydig cell tumor of intermediate differentiation


Pediatric human immunodeficiency virus infection


Invasive Streptococcus pneumoniae disease


Borrelia infection of central nervous system


Cervical Squamous Cell Carcinoma In Situ


INJECTION, AMIFOSTINE, 500 MG ADMINISTERED


Alkylating Agent-Related Acute Myeloid Leukemia


Stage IV Fallopian Tube Cancer AJCC v6 and v7


Autologous Dendritic Cell-Adenovirus P53 Vaccine


Oncolytic Newcastle Disease Virus Strain PV701


Autologous Immunoglobulin Idiotype-KLH Conjugate Vaccine


Childhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive


Transgenic Lymphocyte Immunization Vaccine


Monoclonal Antibody GD2 Anti-Idiotype Vaccine


AIDS-Related Diffuse Large B-cell Lymphoma


Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome


Adult Acute Lymphoblastic Leukemia in Complete Remission


Adult Acute Monoblastic and Monocytic Leukemia


Adult Desmoplastic Small Round Cell Tumor


Adult Lymphocyte-Rich Classical Hodgkin Lymphoma


Adult Primary Cutaneous Anaplastic Large Cell Lymphoma


Adult Systemic Anaplastic Large Cell Lymphoma


Metastatic Breast Carcinoma in the Brain


Metastatic Breast Carcinoma in the Liver


Childhood Acute Lymphoblastic Leukemia in Complete Remission


Childhood Acute Monoblastic and Monocytic Leukemia


Childhood Anaplastic Large Cell Lymphoma


Childhood Clear Cell Sarcoma of Soft Parts


Childhood Desmoplastic Small Round Cell Tumor


Childhood Lymphocyte-Rich Classic Hodgkin Lymphoma


Childhood Nodular Lymphocyte Predominant Hodgkin Lymphoma


Chronic Lymphocytic Leukemia with Unmutated Immunoglobulin Heavy Chain Variable-Region Gene


Colorectal Adenoma with Severe Dysplasia


Complex Endometrial Hyperplasia with Atypia


Diffuse Large B-Cell Lymphoma Post-Transplant Lymphoproliferative Disorder


FIGO Stage III Gestational Trophoblastic Tumor


FIGO Stage II Gestational Trophoblastic Tumor


FIGO Stage I Gestational Trophoblastic Tumor


Gastrointestinal Stromal Tumor of the Gastrointestinal Tract


Head and Neck Basaloid Squamous Cell Carcinoma


Hemangioblastoma of central nervous system


Hereditary Nonpolyposis Colorectal Cancer


High Grade Anal Canal Intraepithelial Neoplasia


High Grade Cervical Intraepithelial Neoplasia


Human Papillomavirus-Related Anal Squamous Cell Carcinoma


Human Papillomavirus-Related Cervical Squamous Cell Carcinoma


Human Papillomavirus-Related Cervical Adenocarcinoma


Human Papillomavirus-Related Malignant Neoplasm


Human Papillomavirus-Related Vulvar Squamous Cell Carcinoma


Lymphomatous Adult T-Cell Leukemia/Lymphoma


Childhood Malignant Central Nervous System Neoplasm


Metastatic well-differentiated neuroendocrine tumor


Metastatic Carcinoma in the Adrenal Cortex


Metastatic Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor


Metastatic Malignant Peripheral Nerve Sheath Tumor


Metastatic Adult Malignant Neoplasm in the Brain


Testicular Mixed Embryonal Carcinoma and Yolk Sac Tumor with Seminoma


Monomorphic B-Cell Post-Transplant Lymphoproliferative Disorder


Monomorphic Post-Transplant Lymphoproliferative Disorder


Plasmacytic Hyperplasia Post-Transplant Lymphoproliferative Disorder


Poorly Differentiated Malignant Neoplasm


Systemic Anaplastic Large Cell Lymphoma, ALK-Negative


Prostate Carcinoma Metastatic in the Bone


Recurrent Anaplastic Large Cell Lymphoma


Recurrent Childhood Central Nervous System Neoplasm


Recurrent Female Reproductive System Carcinoma


Recurrent Male Reproductive System Carcinoma


Recurrent Malignant Peripheral Nerve Sheath Tumor


Recurrent Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma


Recurrent Neck Squamous Cell Carcinoma of Unknown Primary


Recurrent Nodular Lymphocyte Predominant B-Cell Lymphoma


Recurrent Peripheral Primitive Neuroectodermal Tumor


Recurrent Primitive Neuroectodermal Tumor


Refractory Mature B-Cell Non-Hodgkin Lymphoma


Refractory Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma


Refractory Nodular Lymphocyte Predominant B-Cell Lymphoma


Differentiated vulvar intraepithelial neoplasia


Small Lymphocytic Lymphoma with Unmutated Immunoglobulin Heavy Chain Variable-Region Gene


Smoldering Adult T-Cell Leukemia/Lymphoma


Solar Radiation-Related Cutaneous Melanoma


Stage IA Fallopian Tube Cancer AJCC v6 and v7


Stage IA Lung Non-Small Cell Carcinoma AJCC v7


Stage IB Fallopian Tube Cancer AJCC v6 and v7


Stage IB Non-Small Cell Lung Carcinoma AJCC v7


Stage IC Fallopian Tube Cancer AJCC v6 and v7


Stage IIA Esophageal Adenocarcinoma AJCC v7


Stage IIA Fallopian Tube Cancer AJCC v6 and v7


Stage IIA Non-Small Cell Lung Carcinoma AJCC v7


Stage IIA Ovarian Germ Cell Tumor AJCC v6 and v7


Stage IIB Esophageal Adenocarcinoma AJCC v7


Stage IIB Fallopian Tube Cancer AJCC v6 and v7


Stage IIB Cutaneous Melanoma AJCC v6 and v7


Stage IIB Non-Small Cell Lung Carcinoma AJCC v7


Stage IIB Ovarian Germ Cell Tumor AJCC v6 and v7


Stage IIC Fallopian Tube Cancer AJCC v6 and v7


Stage IIC Ovarian Germ Cell Tumor AJCC v6 and v7


Stage IIIA Cervical Cancer AJCC v6 and v7


Stage IIIA Uterine Corpus Cancer AJCC v7


Stage IIIA Fallopian Tube Cancer AJCC v7


Stage IIIA Hepatocellular Carcinoma AJCC v7


Stage IIIA Lung Large Cell Carcinoma AJCC v7


Stage IIIA Ovarian Germ Cell Tumor AJCC v6 and v7


Stage IIIA Lung Small Cell Carcinoma AJCC v7


Stage IIIB Cervical Cancer AJCC v6 and v7


Stage IIIB Uterine Corpus Cancer AJCC v7


Stage IIIB Fallopian Tube Cancer AJCC v7


Stage IIIB Hepatocellular Carcinoma AJCC v7


Stage IIIB Lung Large Cell Carcinoma AJCC v7


Stage IIIB Ovarian Germ Cell Tumor AJCC v6 and v7


Stage IIIB Lung Small Cell Carcinoma AJCC v7


Stage IIIC Uterine Corpus Cancer AJCC v7


Stage IIIC Fallopian Tube Cancer AJCC v7


Stage IIIC Ovarian Germ Cell Tumor AJCC v6 and v7


Stage III Ampulla of Vater Cancer AJCC v7


Stage III Extragonadal Non-Seminomatous Germ Cell Tumor


Stage III Ovarian Embryonal Carcinoma AJCC v6 and v7


Stage III Ovarian Yolk Sac Tumor AJCC v6 and v7


Stage III Pleural Malignant Mesothelioma AJCC v7


Stage III Renal Pelvis and Ureter Cancer AJCC v7


Stage III Lung Small Cell Carcinoma AJCC v7


Stage III Thyroid Gland Medullary Carcinoma AJCC v7


Stage III Thyroid Gland Papillary Carcinoma AJCC v7


Stage II Ovarian Embryonal Carcinoma AJCC v6 and v7


Stage II Ovarian Yolk Sac Tumor AJCC v6 and v7


Stage II Pleural Malignant Mesothelioma AJCC v7


Stage II Renal Pelvis and Ureter Cancer AJCC v7


Stage IVA Hepatocellular Carcinoma AJCC v7


Stage IVA Hypopharyngeal Squamous Cell Carcinoma AJCC v7


Stage IVA Laryngeal Squamous Cell Carcinoma AJCC v7


Stage IVA Laryngeal Verrucous Carcinoma AJCC v7


Stage IVA Major Salivary Gland Cancer AJCC v7


Stage IVA Nasopharyngeal Carcinoma AJCC v7


Stage IVA Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7


Stage IVA Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7


Stage IVA Oral Cavity Cancer AJCC v6 and v7


Stage IVA Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7


Stage IVA Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


Stage IVA Oral Cavity Verrucous Carcinoma


Stage IVA Oropharyngeal Carcinoma AJCC v7


Stage IVA Oropharyngeal Squamous Cell Carcinoma AJCC v7


Stage IVB Hepatocellular Carcinoma AJCC v7


Stage IVB Hypopharyngeal Squamous Cell Carcinoma AJCC v7


Stage IVB Laryngeal Squamous Cell Carcinoma AJCC v7


Stage IVB Laryngeal Verrucous Carcinoma AJCC v7


Stage IVB Major Salivary Gland Cancer AJCC v7


Stage IVB Nasopharyngeal Carcinoma AJCC v7


Stage IVB Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7


Stage IVB Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7


Stage IVB Oral Cavity Cancer AJCC v6 and v7


Stage IVB Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7


Stage IVB Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


Stage IVB Oral Cavity Verrucous Carcinoma


Stage IVB Oropharyngeal Carcinoma AJCC v7


Stage IVB Oropharyngeal Squamous Cell Carcinoma AJCC v7


Stage IVC Hypopharyngeal Squamous Cell Carcinoma AJCC v7


Stage IVC Laryngeal Squamous Cell Carcinoma AJCC v7


Stage IVC Laryngeal Verrucous Carcinoma AJCC v7


Stage IVC Major Salivary Gland Cancer AJCC v7


Stage IVC Nasopharyngeal Carcinoma AJCC v7


Stage IVC Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7


Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7


Stage IVC Oral Cavity Cancer AJCC v6 and v7


Stage IVC Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7


Stage IVC Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


Stage IVC Oral Cavity Verrucous Carcinoma


Stage IVC Oropharyngeal Squamous Cell Carcinoma AJCC v7


Stage IV Ampulla of Vater Cancer AJCC v7


Stage IV Extragonadal Non-Seminomatous Germ Cell Tumor


Stage IV Ovarian Embryonal Carcinoma AJCC v6 and v7


Stage IV Ovarian Yolk Sac Tumor AJCC v6 and v7


Stage IV Pleural Malignant Mesothelioma AJCC v7


Stage IV Renal Pelvis and Ureter Cancer AJCC v7


Stage IV Lung Small Cell Carcinoma AJCC v7


Stage IV Thyroid Gland Medullary Carcinoma AJCC v7


Bladder transitional cell carcinoma stage I


Stage I Ovarian Embryonal Carcinoma AJCC v6 and v7


Stage I Ovarian Yolk Sac Tumor AJCC v6 and v7


Stage I Pleural Malignant Mesothelioma AJCC v7


Testicular Mixed Choriocarcinoma and Embryonal Carcinoma


Testicular Mixed Choriocarcinoma and Seminoma


Testicular Mixed Choriocarcinoma and Teratoma


Testicular Mixed Embryonal Carcinoma and Seminoma


Testicular Mixed Embryonal Carcinoma and Teratoma


Testicular Mixed Embryonal Carcinoma and Teratoma with Seminoma


Testicular Mixed Embryonal Carcinoma and Yolk Sac Tumor


Testicular Mixed Yolk Sac Tumor and Teratoma


Testicular Mixed Yolk Sac Tumor and Teratoma with Seminoma


Treatment related acute myeloid leukaemia


Undifferentiated Fallopian Tube Carcinoma


Recurrent Childhood Hepatocellular Carcinoma


Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive


Childhood Central Nervous System Teratoma


Childhood Central Nervous System Neoplasm


lung; disease, interstitial, with fibrosis


disease (or disorder); intervertebral disc, myelopathy (etiology)


anesthesia; adverse effect, spinal and epidural


aspergillosis; pulmonary, invasive (etiology)


Mycobacterium; atypical, pulmonary, tuberculous


delayed; delivery, following rupture of membranes (spontaneous)


premature rupture of membranes affecting fetus


c.delivery; previous surgery, gynecological


cardiac; prosthesis, heart, functional disturbance as result


cervix; insufficient dilatation in labor


cesarean section; complications, wound, infection (following delivery)


complications; artificial fertilization, introduction of embryo in embryo transfer


complications; medical care, late effect of complications


complications; penile prosthesis, infection or inflammation


complications; vaccination, reaction, serum


coronavirus as cause of disease classified elsewhere


Displacement of cervical intervertebral disc


pulmonary embolism with acute cor pulmonale


fetus or newborn; effects of induction of labor


agitated; state, acute reaction to stress


effects of; anesthesia, in labor and delivery


effects of; anesthesia, spinal and epidural, in pregnancy


heart; surgery, heart, functional disturbance as result


cardiac; complications, valve, prosthesis


heart; dysfunction postoperative, cardiac surgery


suture; complications, infection or inflammation


Hemorrhagic disorder due to circulating anticoagulants


lesion; vascular, central nervous system


lung transplant; complications, mechanical


breast prosthesis; infection or inflammation


maternal; pre-eclampsia, affecting fetus


radicular; neuropathic, lumbar, lumbosacral


respiration; insufficient or poor, newborn


neuropathy; radicular, lumbar, lumbosacral


hypertrophy; mucous membrane nose (turbinate)


disorder; heart, functional, postoperative, cardiac surgery


labor; forced or induced, affecting fetus or newborn


Disodium ascorbyl phytostanol phosphates


Non-proteinuric hypertension of pregnancy


West Nile Fever with other complications


Carnitine palmitoyltransferase deficiencies (CPT1, CPT2)


Traumatic AND/OR non-traumatic brain injury


Harmful pattern of use of methamphetamine


Still's disease with juvenile onset and/or adult onset


INJECTION, BEVACIZUMAB, 10 MG, Administered


Injection, cetuximab, 10 mg administered


Injection, omalizumab, 5 mg administered


MYCOPHENOLIC ACID, ORAL, 180 MG ADMINISTERED


INJECTION, VERTEPORFIN, 0.1 MG ADMINISTERED


C-KIT Tyrosine Kinase Protein Overexpression


FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma


FIGO Grade 2 Endometrial Endometrioid Adenocarcinoma


Endometrial High Grade Endometrioid Adenocarcinoma


High Grade B-Cell Non-Hodgkin's Lymphoma


Cervical high grade squamous intraepithelial lesion


Medicinal product acting as imaging agent (product)


Invasive Bladder Giant Cell Urothelial Carcinoma


Invasive Bladder Urothelial Carcinoma with Glandular Differentiation


Invasive Bladder Urothelial Carcinoma with Squamous Differentiation


Invasive Bladder Urothelial Carcinoma with Trophoblastic Differentiation


Intermediate Grade B-Cell Non-Hodgkin's Lymphoma


Mitogen-Activated Protein Kinase Inhibitor


Prostate Adenocarcinoma with Neuroendocrine Differentiation


Recombinant Vaccinia-Prostate Specific Antigen


Luteinizing Hormone-releasing Hormone Agonist


Malignant Ovarian Mixed Epithelial Tumor


Non-Neoplastic Hematopoietic and Lymphoid Cell Disorder


Positive Regulation of Oxidative Stress Process


Selective Estrogen Receptor Down Regulator


Signal Transduction Pathway Deregulation


Gastrointestinal Intraepithelial Neoplasia of Mouse


Recombinant Vascular Endothelial Growth Factor


Recombinant Tumor Necrosis Factor Family Protein


TRIad of COstimulatory Molecules (B7-1, ICAM-1, LFA-3)


bleeding tendency; due to coagulation defect


Chronic myeloid leukemia in myeloid blast crisis


Emtricitabine- and tenofovir-containing product


chronic diabetic foot ulcer of right foot


Non ST segment elevation myocardial infarction


Extracorporeal membrane oxygenation complication


Closed reduction of fracture and application of plaster cast


CoFactor brand of 5,10-methylenetetrahydrofolate


Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11


adult acute myeloid leukemia with inv(16)(p13;q22)


Adult Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A


Allogeneic GM-CSF-Secreting Breast Cancer Vaccine


Childhood Grade III Lymphomatoid Granulomatosis


Recurrent Childhood Grade III Lymphomatoid Granulomatosis


Adult Grade III Lymphomatoid Granulomatosis


Recurrent Adult Grade III Lymphomatoid Granulomatosis


Fetus or newborn affected by alcohol transmitted via placenta or breast milk


A variant not otherwise specified Antigen


Encounter Admission Source - labor and delivery


Adverse Event Associated with Cardiac Arrhythmia


Chronic kidney disease, Stage III (moderate)


Chronic kidney disease, stage 4 (severe)


Non-ST elevation (NSTEMI) myocardial infarction


Hormone receptor positive malignant neoplasm of breast


Hemoglobin S sickling disorder with crisis


Preterm Premature Rupture of Fetal Membranes


Progesterone, Micronized 100 MG Vaginal Kit


Diphtheria Toxoid/Tetanus Toxoid/Acellular Pertussis Vaccine Adsorbed


Serotonin and Norepinephrine Reuptake Inhibitors (SNRIs)


Immunodeficiency with predominant T-cell defect, unspecified


Emtricitabine/ Tenofovir Disoproxil Fumarate


Injection, ziconotide, 1 microgram administered


INJECTION, APOMORPHINE HYDROCHLORIDE, 1 MG ADMINISTERED


INJECTION, PACLITAXEL PROTEIN-BOUND PARTICLES, 1 MG


Indium in-111 pentetate, diagnostic, per 0.5 millicurie


Technetium tc-99m pentetate, diagnostic, per study dose, up to 25 millicuries


INJECTION, HISTRELIN ACETATE, 10 MICROGRAMS ADMINISTERED


Injection, azacitidine, 1 mg administered


Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries


DEXAMETHASONE, ORAL, 0.25 MG ADMINISTERED


INJECTION, PEGAPTANIB SODIUM, 0.3 MG Administered


Adult Diffuse Small Cleaved Cell Lymphoma


Adverse reaction to influenza virus vaccine


Propensity to adverse reactions to food (finding)


retained products of conception post abortion


infection secondary to surgical procedure


Night Time brand of acetaminophen, dextromethorphan, doxylamine, and pseudoephedrine


Vaccine product containing only Neisseria meningitidis conjugated antigen


Atypical teratoid/rhabdoid tumour of central nervous system


Associated Pulmonary Arterial Hypertension


Interleukin 1 Receptor Antagonist Protein


HLA-A1, A2, B35-Restricted Survivin Peptides/Montanide ISA-51 Vaccine


Intermediate Grade Lung Neuroendocrine Neoplasm


Laryngeal Spindle Cell Squamous Carcinoma


Localized Unresectable Adult Hepatocellular Carcinoma


Well-differentiated neuroendocrine tumor grade 1 of lung


Mouse Prostate-Specific Membrane Antigen Plasmid DNA Vaccine


Primary Cutaneous Diffuse Large B-Cell Lymphoma, Other


Recurrent Adrenal Gland Pheochromocytoma


Refractory Primary Cutaneous T-Cell Non-Hodgkin Lymphoma


Sporadic Thyroid Gland Medullary Carcinoma


Diffuse large B-cell lymphoma, unclassifiable, NOS


Human Prostate-Specific Membrane Antigen Plasmid DNA Vaccine


Nasopharyngeal Low Grade Papillary Adenocarcinoma


Recurrent Adult Hepatocellular Carcinoma


rabies vaccine, purified chick embryo cell


myelodysplastic syndrome with low-grade lesions


myelodysplastic syndrome with high-grade lesions


Chronic kidney disease requiring chronic dialysis


Peripheral vascular disorder due to diabetes mellitus


Renal disorder due to type 2 diabetes mellitus


Pneumocystosis with AIDS (acquired immunodeficiency syndrome)


Immunoblastic lymphoma associated with AIDS


Female Urogenital Diseases and Pregnancy Complications


Inappropriate device stimulation of tissue


Anal high grade squamous intraepithelial lesion


Acute graft versus host disease in intestine


Progression of non-small cell lung cancer


INJECTION, DECITABINE, 1 MG ADMINISTERED


Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)


Injection, nelarabine, 50 mg administered


PAPILLOMAVIRUS HUMAN QUADRIVALENT VACCINE


acute inflammatory response to non-antigenic stimulus


Non-small cell carcinoma of lung, TNM stage 4


Copper (64-Cu) diacetyl-bis N-(4)-methylthiosemicarbazone


Dementia associated with Parkinson's Disease


Hodgkin's Antigens-GM-CSF-Expressing Cell Vaccine


Recombinant Bispecific Single-Chain Antibody rM28


Long-Term Effects Secondary to Cancer Therapy in Adults


Synthetic Breast Cancer Peptides-Tetanus Toxoid-Montanide ISA-51 Vaccine


Live Freeze-Dried Lactic Acid Bacteria Probiotic


Carcinoembryonic Antigen-Expressing Measles Virus


Anti-Melanin Monoclonal Antibody PTI-6D2


Adult Subependymal Giant Cell Astrocytoma


Childhood Subependymal Giant Cell Astrocytoma


Irritable bowel syndrome characterized by constipation


Follicular B-cell non-Hodgkin's lymphoma


adult nasal type extranodal NK/T-cell lymphoma


childhood nasal type extranodal NK/T-cell lymphoma


Diffuse Hyperplastic Perilobar Nephroblastomatosis


Cell Cycle Checkpoint/DNA Repair Antagonist IC83


Severe Combined Immunodeficiency with Absence of T and B Cells


Folate Receptor-Targeted Technetium Tc-99m EC20


Stage 0a Bladder Urothelial Carcinoma AJCC v6 and v7


Kaposi's sarcoma-associated human herpesvirus infection


extranodal marginal zone B-cell lymphoma


Idiopathic normal pressure hydrocephalus (INPH)


Chronic total occlusion of coronary artery


Epidermal growth factor receptor negative non-small cell lung cancer


Female infertility due to diminished ovarian reserve


Chronic nontraumatic dissection of thoracic aorta


Epidermal growth factor receptor positive non-small cell lung cancer


Beta lactam resistant bacterial infection


Injection, protein c concentrate, intravenous, human, 10 iu


Injection, ranibizumab, 0.1 mg administered


INDIUM IN-111 PENTETREOTIDE, DIAGNOSTIC, PER STUDY DOSE, UP TO 6 MILLICURIES


Low risk of recurrence, prostate cancer (PRCA)


High risk of recurrence, prostate cancer (PRCA)


Injection, levetiracetam, 10 mg administered


DEXTROAMPHETAMINE SULFATE, 5 MG ADMINISTERED


Hypertensive left ventricular hypertrophy


Dependence on dialysis due to end stage renal disease


Disorder related to lung transplantation


Disorder related to cardiac transplantation


Disorder related to renal transplantation


Hypertension secondary to kidney transplant


Disorder related to bone marrow transplantation


insulin aspart, insulin aspart protamine drug combination 30:70


cardiac catheterization cardiac output in liters per minute


Central Nervous System Ganglioneuroblastoma


osteoarthritis of multiple joints of ankle or foot


squamous cell carcinoma of urinary organs


stress echo measurements ejection fraction


Cardiovascular surgery result: exercise tolerance


cardiovascular surgery result: left ventricular function


cervical incompetence in pregnancy as antepartum condition


heavy bleeding between periods (symptom)


hemolytic anemia due to spur cell anemia


3-lead electrocardiogram rhythm strip: heart rate


3-lead electrocardiogram rhythm strip: sinus rhythm


human papilloma virus vaccine, quadrivalent


hyperthyroidism treated or under control


infection due to indwelling urinary catheter


patient appears in no acute distress (physical finding)


primary aldosteronism due to aldosterone producing adenoma


primary aldosteronism due to bilateral adrenal hyperplasia


primary aldosteronism due to nodular hyperplasia


drug resistant Plasmodium falciparum malaria


complicated coal workers' pneumoconiosis


nonsteroidal anti-inflammatory drugs (NSAIDs) toxicity


pediatric presentation of urinary tract infection


mucinous cystic neoplasm with moderate dysplasia


adenocarcinoma of lung metastatic to brain


malignant neoplasm of stomach metastatic to regional lymph nodes


malignant neoplasm of pancreas metastatic to liver


malignant neoplasm of pancreas metastatic to peritoneal surface


malignant neoplasm of esophagus metastatic to liver


malignant neoplasm of esophagus metastatic to lung


malignant neoplasm of esophagus metastatic to bone


undifferentiated carcinoma of anal canal


Norethindrone Acetate and Ethinyl Estradiol


childhood asthma with acute exacerbation


childhood asthma with status asthmaticus


chronic atrophic gastritis with hyperplasia


chronic renal failure with uremic nephropathy


chronic hepatitis D infection with hepatitis B


inhaled beclomethasone dipropionate monohydrate


physical trauma to surgical incision (history)


bacterial pleural effusion other than tuberculosis


Betamethasone Sodium Phosphate Injection


disorders of calcium and bone metabolism


localized primary osteoarthritis of knee


complication of coronary artery bypass graft


continuous electrocardiogram sinus bradycardia


continuous electrocardiogram ventricular fibrillation


continuous electrocardiogram ventricular tachycardia


postpartum history insufficient lactation


previous premature rupture of membranes (history)


malignant neoplasm of fourth ventricle of brain


total parenteral nutrition-induced cholestasis


misadventure during aspirating needle biopsy


late complication from kidney transplant


reported crush injury of tissue (history)


transvaginal ultrasound: length of cervix


recent aspiration of gastric contents (history)


rectal discharge diarrhea (physical finding)


renal transplant candidate for left kidney


renal transplant candidate for right kidney


History of gestational diabetes mellitus


long-chain hydroxyacyl-CoA dehydrogenase deficiency


reported family history of birth defects (history)


reported prior thyroid disease (history)


unreasonable fear being in open spaces or crossing bridges


services source emergency medical services (ambulance)


do not feel rested after adequate night's sleep


marginal zone lymphoma of mucosa-associated lymphoid tissue


adverse effect of drug therapy metabolism medications


acute therapy-related myelogenous leukemia


atypical teratoid/rhabdoid tumor of brain


malignant melanoma of skin TNM staging primary tumor (T) T0


malignant neoplasm of bladder TNM staging distant metastasis (M) M0


malignant neoplasm of bladder TNM staging primary tumor (T) T2


malignant neoplasm of bladder TNM staging primary tumor (T) T2a


malignant neoplasm of bladder TNM staging primary tumor (T) T2b


malignant neoplasm of bladder TNM staging primary tumor (T) T3


malignant neoplasm of bladder TNM staging primary tumor (T) T3a


malignant neoplasm of bladder TNM staging primary tumor (T) T3b


malignant neoplasm of bladder TNM staging regional lymph node (N) N0


malignant neoplasm of bladder TNM staging regional lymph node (N) N1


malignant neoplasm of cervix TNM staging regional lymph nodes (N)


malignant neoplasm of esophagus stage IIb


malignant neoplasm of esophagus stage IVb


malignant neoplasm of esophagus TNM staging primary tumor (T) T4


malignant neoplasm of thyroid TNM staging


malignant non-small cell neoplasm of lung stage IV


sodium ferric gluconate complex in sucrose


meningococcal conjugate vaccine, serogroup A


erythroblastosis fetalis due to isoimmunization


severe acute respiratory syndrome (SARS) pneumonia


moisture of mucous membranes (physical finding)


ADHD, predominantly hyperactive - impulsive


benign prostatic hypertrophy with urinary obstruction with other lower urinary tract symptoms


Gall stones (& [calculus - gall bladder])


macrocytic anemia with vitamin B12 deficiency


Hyperacute rejection of cardiac transplant


Infection of total knee joint prosthesis


Peripheral nerve disorder associated with repair of hernia


Autologous Dendritic Cell-Adenovirus CCL21 Vaccine


Autologous Dendritic Cell-Tumor Fusion Vaccine


Modified Vaccinia Ankara (Bavarian Nordic)-HER2 Vaccine


Malignant Glioma Tumor Lysate-Pulsed Autologous Dendritic Cell Vaccine


Mitogen-Activated Protein Kinase Kinase Inhibitor


Childhood B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1


Plant-Derived Hematopoiesis Enhancer PG2


Childhood Atypical Teratoid/Rhabdoid Tumor


Salivary Gland Poorly Differentiated Squamous Cell Carcinoma


Adult Supratentorial Embryonal Tumor, Not Otherwise Specified


Recombinant Adenovirus-Interferon SCH 721015


Recurrent Childhood Spinal Cord Neoplasm


Refractory Primary Central Nervous System Neoplasm


Cysteine-Rich Non-Denatured Whey Protein Isolate IMN1207


Sialyl Lewis-Keyhole Limpet Hemocyanin Conjugate Vaccine


Doxorubicin-GNRH Agonist Conjugate AEZS-108


FLT3 Tyrosine Kinase Domain Point Mutation


Standardized Freeze-Dried Table Grape Powder


Testicular Mixed Choriocarcinoma and Yolk Sac Tumor


Human Papilloma Virus L1 Virus-Like Particle V504 Vaccine


Multiple myeloma, without mention of having achieved remission


High grade neuroendocrine carcinoma, any site


Acute on chronic graft-versus-host disease


Methicillin susceptible Staphylococcus aureus septicemia


Disruption or dehiscence of closure of sternum or sternotomy


Clinically Isolated Syndrome, CNS Demyelinating


yellow fever virus strain 17D-204 live antigen


Capsular contracture associated with breast implant


rotavirus vaccine, live attenuated, G1P[8] human 89-12 strain


acute undifferentiated leukemia in relapse


amniocentesis affecting fetus or newborn


high grade malignant neuroendocrine carcinoma


poorly differentiated malignant neuroendocrine carcinoma


Injection, ixabepilone, 1 mg administered


Hereditary factor IX deficiency disease with inhibitor


Mild hereditary factor VIII deficiency disease without inhibitor


Moderate hereditary factor VIII deficiency disease without inhibitor


Severe hereditary factor VIII deficiency disease without inhibitor


Siewert type I adenocarcinoma of esophagogastric junction


Hemoglobin SS disease with vasoocclusive crisis


Siewert type II adenocarcinoma of esophagogastric junction


Nonsquamous nonsmall cell neoplasm of lung


quetiapine 50 MG Extended Release Oral Tablet


Pancreatic neuroendocrine tumour metastatic


Adrenomyeloneuropathy without cerebral involvement


Medrol 4 MG Oral Tablet includes Medrol Dosepak


darifenacin 7.5 MG Extended Release Oral Tablet


Ipratropium bromide 20micrograms breath-actuated aerosol inhaler


Hypodiploid B Acute Lymphoblastic Leukemia


Allogeneic Large Multivalent Immunogen Breast Cancer Vaccine


Anti-Myeloma Monoclonal Antibody-DM4 Immunoconjugate BT-062


High Grade B-Cell Lymphoma, Not Otherwise Specified


Pleomorphic Variant Mantle Cell Lymphoma


Macrogol 3350-Based Iso-Osmotic Laxative


Polyvalent antigen-KLH conjugate vaccine


Prostate Health Cocktail Dietary Supplement


vaccinia virus strain New York City Board of Health live antigen


Anti-Integrin Monoclonal Antibody-DM4 Immunoconjugate IMGN388


lamotrigine 25 MG Oral Tablet includes 35 Count Pack


Failure of osseointegration of dental implant


Moderate hypoxic ischemic encephalopathy


Failed moderate sedation during procedure


Infection by Klebsiella pneumoniae in conditions classified elsewhere and of unspecified site


Antineoplastic chemotherapy induced anemia


Failed conscious sedation during procedure


Epilepsy, unspecified, refractory (medically)


SODIUM FLUORIDE F-18, DIAGNOSTIC, PER STUDY DOSE, UP TO 30 MILLICURIES


Upper Extremity Deep Vein Thrombosis, Secondary


influenza virus vaccine trivalent 2009-2010


methylphenidate poisoning of undetermined intent


acute thrombosis of deep veins of lower extremity


anemia as adverse effect of chemotherapeutics


conscious sedation failure during procedure


INJECTION, TEMOZOLOMIDE, 1 MG, ADMINISTERED


INJECTION, BEVACIZUMAB, 0.25 MG, Administered


Multiple system atrophy, cerebellar variant


Ductal Carcinoma In Situ with Microinvasion


Multiple system atrophy, Parkinson's variant


Berberis vulgaris homeopathic preparation


Adult Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB-MYH11


Anti-CEA/Anti-HSG Bispecific Monoclonal Antibody TF2


Recombinant Saccharomyces Cerevisia-CEA(610D)-Expressing Vaccine GI-6207


Enteric-Coated TRPM8 Agonist D-3263 Hydrochloride


Liver Disease Associated with Cystic Fibrosis


Human Trefoil Factor 1-Secreting Lactococcus lactis AG013


DEC-205/NY-ESO-1 Fusion Protein CDX-1401


Stage IIA Cutaneous Melanoma AJCC v6 and v7


Stage IIC Cutaneous Melanoma AJCC v6 and v7


HPV positive oropharyngeal squamous cell carcinoma


Stage I Gestational Trophoblastic Tumor AJCC v7


Stage II Gestational Trophoblastic Tumor AJCC v7


Stage III Gestational Trophoblastic Tumor AJCC v7


Injury of facial nerve, unspecified side, initial encounter


SARS-associated coronavirus as cause of disease classified elsewhere


Fracture of posterior wall of acetabulum


Unspecified injury of brachial artery, left side, initial encounter


Injuries to the wrist, hand and fingers (S60-S69)


CD30-positive diffuse large B-cell lymphoma


Acute lymphoblastic leukemia with failed remission


Acute Lymphoblastic Leukemia not Having Achieved Remission


Acute lymphoblastic leukemia, in relapse


Injury of other nerves at wrist and hand level of unspecified arm, initial encounter


Chronic myelogenous leukemia with crisis of blast cells


Chronic myeloid leukemia, BCR/ABL-positive


Chronic myeloid leukemia, BCR/ABL-positive, in remission


acute myelomonocytic leukemia in relapse


Acute myeloid leukemia with 11q23-abnormality in relapse


Hb-SS disease with (vaso-occlusive) pain


Other sickle-cell disorders with crisis, unspecified


Erythropoietin resistant anemia (EPO resistant anemia)


C1 esterase inhibitor [C1-INH] deficiency


Type 1 diabetes mellitus with diabetic gastroparesis


Type 2 diabetes mellitus with kidney complications


diabetes mellitus type 2 with hyperglycemia


nicotine dependence - cigarettes - with withdrawal


Nicotine dependence, other tobacco product


Drug-Induced Movement Disorder, Unspecified


Chronic intractable migraine without aura


Complex regional pain syndrome I, unspecified


Chalazion unspecified eye, unspecified eyelid


Poisoning by, adverse effect of and underdosing of antiviral drugs


Poisoning by, adverse effect of and underdosing of oral contraceptives


Adverse effect of oral contraceptives, sequela


Poisoning by, adverse effect of and underdosing of other hormone antagonists


Underdosing of unspecified general anesthetics


Poisoning by, adverse effect of and underdosing of other general anesthetics


Adverse effect of other general anesthetics


Poisoning by, adverse effect of and underdosing of local anesthetics


Underdosing of local anesthetics, initial encounter


Poisoning by, adverse effect of and underdosing of benzodiazepines


Poisoning by, adverse effect of and underdosing of other antidepressants


Adverse effect of other antipsychotics and neuroleptics


Poisoning by, adverse effect of and underdosing of methylphenidate


Poisoning by, adverse effect of and underdosing of other psychotropic drugs


Poisoning by, adverse effect of and underdosing of anticoagulants


Poisoning by, adverse effect of and underdosing of other antihypertensive drugs


Drusen (degenerative) of macula, bilateral


Nontraumatic Intracerebral Hemorrhage, Multiple Localized


Esophageal varices secondary to cirrhosis of liver


Other intraoperative cardiac functional disturbances during cardiac surgery


White spot lesions [initial caries] on smooth surface of tooth


Eosinophilic gastritis or gastroenteritis


Malposition of intrauterine contraceptive device


Complications of transplanted organs and tissue


Unspecified complication of liver transplant


Unspecified complication of corneal transplant


Stiffness of unspecified joint, not elsewhere classified


Stiffness of knee, not elsewhere classified


Sciatica due to intervertebral disc disorder


Adhesive capsulitis of unspecified shoulder


Medial epicondylitis of right elbow joint


Medial epicondylitis of left elbow joint


Lateral epicondylitis, unspecified elbow


Male infertility due to hypospermatogenesis


Erectile dysfunction due to arterial insufficiency


Erectile dysfunction following radical prostatectomy


Female infertility due to tubal occlusion


Female infertility due to nonimplantation of ovum


Supervision of pregnancy resulting from in-vitro fertilization


Gestational diabetes mellitus in pregnancy


Preterm labor in third trimester with preterm delivery in third trimester


Encounter due to family history of colonic polyps


Encounter due to family history of osteoporosis


Recombinant Human Deoxyribonuclease 1 [EPC]


Monoamine Oxidase Type B Inhibitor [EPC]


Encounter due to estrogen receptor status


Encounter due to problems related to other legal circumstances - arrest


Glucose transporter protein type 1 deficiency syndrome


Macroalbuminuric nephropathy due to diabetes mellitus


Glucose in blood specimen above reference range


Surviving free of recurrence of neoplastic disease


passiflora incarnata flowering top extract


Iron overload due to repeated red blood cell transfusions


Transfusion associated circulatory overload


Recurrent pregnancy loss without current pregnancy


estradiol / ethinyl estradiol / levonorgestrel


Lynch syndrome I (site-specific colonic cancer)


Multiple system atrophy (MSA) with orthostatic hypotension


Clear-cell metastatic renal cell carcinoma


PERFLUTREN 6.52 mg in 1 mL INTRAVENOUS INJECTION, SUSPENSION [Definity]


Attention deficit hyperactivity disorder, combined type


Injection, telavancin, 10 mg administered


Injection, canakinumab, 1 mg administered


Injection, tocilizumab, 1 mg administered


Small bowel bacterial overgrowth syndrome


Heart failure with normal ejection fraction


Reactivation of hepatitis B viral hepatitis


Glucose 500 MG/ML includes Injection & Prefilled Syringe


Arteriovenous fistula only (in use with two needles)


Furunculosis of skin AND/OR subcutaneous tissue


Myelodysplastic syndrome with low blasts (disorder)


Stage III Mucosal Melanoma of the Head and Neck AJCC v7


Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7


Stage IVB Mucosal Melanoma of the Head and Neck AJCC v7


Stage IVC Mucosal Melanoma of the Head and Neck AJCC v7


Stage III Differentiated Thyroid Gland Carcinoma AJCC v7


Stage IVA Differentiated Thyroid Gland Carcinoma AJCC v7


Stage IVB Differentiated Thyroid Gland Carcinoma AJCC v7


Stage IVC Differentiated Thyroid Gland Carcinoma AJCC v7


Stage IVA Thyroid Gland Medullary Carcinoma AJCC v7


Stage IVB Thyroid Gland Medullary Carcinoma AJCC v7


Stage IVC Thyroid Gland Medullary Carcinoma AJCC v7


Stage IVA Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v7


Stage IVB Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v7


Stage IVC Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v7


Stage IB Esophageal Adenocarcinoma AJCC v7


Stage IIIA Esophageal Adenocarcinoma AJCC v7


Stage IIIB Esophageal Adenocarcinoma AJCC v7


Stage IIIC Esophageal Adenocarcinoma AJCC v7


Stage IIIB Esophageal Squamous Cell Carcinoma AJCC v7


Stage IIIC Esophageal Squamous Cell Carcinoma AJCC v7


Stage IIIA Small Intestinal Cancer AJCC v7


Stage IIIB Small Intestinal Cancer AJCC v7


Secondary Central Nervous System Lymphoma


Clevidipine Butyrate Injectable Emulsion


Stage IIIC Hepatocellular Carcinoma AJCC v7


Stage III Intrahepatic Cholangiocarcinoma AJCC v7


Stage IVA Intrahepatic Cholangiocarcinoma AJCC v7


Stage IVB Intrahepatic Cholangiocarcinoma AJCC v7


Stage IIIA Hilar Cholangiocarcinoma AJCC v7


Stage IIIB Hilar Cholangiocarcinoma AJCC v7


Stage IVA Hilar Cholangiocarcinoma AJCC v7


Stage IVB Hilar Cholangiocarcinoma AJCC v7


Stage IV Distal Bile Duct Cancer AJCC v7


Stage IA Pancreatic Cancer AJCC v6 and v7


Stage IB Pancreatic Cancer AJCC v6 and v7


Stage IIA Pancreatic Cancer AJCC v6 and v7


Stage IIB Pancreatic Cancer AJCC v6 and v7


Stage IA Mycosis Fungoides and Sezary Syndrome AJCC v7


Stage IB Mycosis Fungoides and Sezary Syndrome AJCC v7


Stage IIA Mycosis Fungoides and Sezary Syndrome AJCC v7


Stage IIB Mycosis Fungoides and Sezary Syndrome AJCC v7


Stage IIIA Mycosis Fungoides and Sezary Syndrome AJCC v7


Stage IIIB Mycosis Fungoides and Sezary Syndrome AJCC v7


Stage IVA Mycosis Fungoides and Sezary Syndrome AJCC v7


Stage IVB Mycosis Fungoides and Sezary Syndrome AJCC v7


Fumagillin-Derived Polymer Conjugate XMT-1107


Anti-CAIX Antibody-Drug Conjugate BAY79-4620


Stage II Nasopharyngeal Carcinoma AJCC v7


Adenovirus-p53 Transduced Dendritic Cell Vaccine


CEA/Tetanus Toxoid T Helper Epitope Fusion Protein-Expressing DNA Plasmid Vaccine


Eg5 Kinesin-Related Motor Protein Inhibitor 4SC-205


Autologous Melanoma Lysate-Pulsed Autologous Dendritic Cell Vaccine


Heat-Treated Varicella-Zoster Virus Vaccine V212


Diphtheria Toxoid/Tetanus Toxoid Vaccine Adsorbed


Indoleamine 2,3-dioxygenase Peptide Vaccine


Stage III Childhood Non-Hodgkin Lymphoma


Ann Arbor Stage II AIDS-Related Lymphoma


Ann Arbor Stage III AIDS-Related Lymphoma


Ann Arbor Stage IV AIDS-Related Lymphoma


Congenital Bone Marrow Failure Syndromes


Stage III Borderline Ovarian Surface Epithelial-Stromal Tumor


Stage IV Borderline Ovarian Surface Epithelial-Stromal Tumor


Anti-human GITR Monoclonal Antibody TRX518


Stage IIIC1 Uterine Corpus Cancer AJCC v7


Stage IIIC2 Uterine Corpus Cancer AJCC v7


pUMVC3-hIGFBP-2 Multi-epitope Plasmid DNA Vaccine


Anti-CD3/Anti-CD20 Trifunctional Bispecific Monoclonal Antibody FBTA05


Crystalline Genistein Formulation AXP107-11


Cervix Intraepithelial Neoplasia Grade 3 AJCC v7


Stage IV Nasopharyngeal Carcinoma AJCC v7


Pneumococcal 13-valent conjugate vaccine


AMMONIA N-13 37.5 mCi in 1 mL INTRAVENOUS INJECTION


Non ST segment elevation acute coronary syndrome


Squamous cell carcinoma of other specified sites of skin


Basal cell carcinoma of skin, site unspecified


Bloodstream infection due to central venous catheter


Shiga toxin-producing Escherichia coli [E. coli] (STEC), unspecified


bloodstream infection due to Hickman catheter


CLABSI - central line associated bloodstream infection


Complications of other bariatric procedure


Malignant epithelial neoplasm of renal pelvis


Complete obstruction of systemic to pulmonary artery shunt


Non-Hodgkin's lymphoma of extranodal site


Partial obstruction of systemic to pulmonary artery shunt


Bisphosphonate-Associated Osteonecrosis of the Jaw


pegylated granulocyte colony-stimulating factor


Perflutren Lipid Microsphere Intravenous Suspension


Injection, ipilimumab, 1 mg administered


Injection, minocycline hydrochloride, 1 mg administered


Injection, belimumab, 10 mg administered


ONDANSETRON, ORAL, 4 MG (FOR CIRCUMSTANCES FALLING UNDER THE MEDICARE STATUTE, USE HCPCS Q CODE)


complications of organ transplant stem cells


complications of organ transplant stem cells umbilical cord


Thoracic aortic aneurysm without rupture


polyethylene glycol-recombinant human growth hormone


Bone density below reference range (finding)


Anaplastic lymphoma kinase gene mutation


Vascular endothelial growth factor overexpression


Chronic graft versus host disease in skin


PSMA-targeted Docetaxel Nanoparticles BIND-014


Digestive System Neuroendocrine Tumor G2


Live attenuated Influenza virus antigen only vaccine product


meningococcal polysaccharide vaccine (MPSV4)


Small Duct Intrahepatic Cholangiocarcinoma


Gallbladder Adenocarcinoma, Biliary Type


Extrahepatic Bile Duct Adenocarcinoma, Biliary Type


Human Papillomavirus-Related Adenosquamous Carcinoma


PI3K Alpha/mTOR Inhibitor PWT33597 Mesylate


Hafnium oxide-containing nanoparticles nbtxr3


Anti-mesothelin antibody-drug conjugate BAY 94-9343


recombinant MIP1-alpha variant ECI301, Human


Copper Cu 64-DOTA-Anti-HER3 Monoclonal Antibody U3-1287


Systemic lupus erythematosus, childhood onset


Allergen (brand of antipyrine/benzocaine)


varicella-zoster virus vaccine live (Oka-Merck) strain


medical induction of labor affecting fetus


Cystoid macular edema following cataract surgery


Chlamydia trachomatis infection in pregnancy


mirabegron 50 MG Extended Release Oral Tablet


Bacteremia caused by Gram-negative bacteria


Passiflora incarnata homeopathic preparation


Finding relating to sexuality and sexual activity


Patent ductus arteriosus - persisting type


alpha-1-Antitrypsin Deficiency, Autosomal Recessive


displaced articular fracture of head of femur


antipsychotics and neuroleptics toxicity


Chronic obstructive pulmonary disease exacerbation


localized primary osteoarthritis of both hips


stimulant use with stimulant-induced psychotic disorder


Diphtheria and Tetanus Toxoids and Acellular Pertussis Absorbed and Inactivated Poliovirus (DTaP-IPV) Vaccine


diphtheria, tetanus toxoids and acellular pertussis vaccine


Pulmonary hypertension due to left heart disease


History of recurrent urinary tract infection


Exacerbation of congestive heart failure


Injection, ibuprofen, 100 mg administered


Injection, belatacept, 1 mg administered


Injection, aflibercept, 1 mg administered


cytomegalovirus immune globulin, intravenous


N-methyl-D-aspartate Receptor Antagonist [EPC]


Angiotensin Converting Enzyme Inhibitor [EPC]


Nonsteroidal Anti-inflammatory Drug [EPC]


gimeracil + oteracil potassium + tegafur


Gonadotropin Releasing Hormone Antagonist [EPC]


Nucleoside Reverse Transcriptase Inhibitor


Non-nucleoside Reverse Transcriptase Inhibitor


Cannabis-Based Oromucosal Spray GW-1000-02


Serotonin and Norepinephrine Reuptake Inhibitor [EPC]


ESTROGENS, SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM


Corticosteroid nasal preparations for topical use


Prostaglandin drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD)


Non-selective beta-adrenoreceptor agonists for systemic use


opium alkaloids and derivative combination cough suppressants


Other intestinal adsorbent combinations in ATC


Platelet aggregation inhibitor combinations excl. heparin


local opthalmologic anesthetic combinations


insulins and analogs for injection combinations, long-acting


Insulins and analogs for injection, intermediate-acting combined with fast-acting- combinations


combination drugs used in erectile dysfunction


otologic analgesic and anesthetic combinations


Combination solutions for parenteral nutrition


Other antifungal combinations for topical use in ATC


Insulins and analogs for injection, intermediate-acting combinations


Penicillins with extended spectrum combinations


expectorant combinations excluding combinations with cough suppressants


Antiinfective irrigating solution combinations


Proton pump inhibitors for peptic ulcer and GORD


Progestogen systemic hormonal contraceptives


Adrenergic and dopaminergic agents combinations


Other irrigating solution combinations in ATC


other cough suppressant combinations in ATC


ANTIANDROGEN SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM


Antibiotics FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE


ANTIINFECTIVES, OPHTHALMOLOGIC AND OTOLOGIC


other nasal preparation combinations in ATC


Beta-lactamase sensitive penicillin combinations


Insulins and analogs for injection, fast-acting combinations


expectorant combinations, excl. combinations with cough suppressants


Corticosteroid ophthalmologic and otologic preparations


Corticosteroids, topical for treatment of hemorrhoids and anal fissures


PROGESTOGEN SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM


Prostaglandin cardiac therapy preparations


Protease inhibitors, direct acting antivirals


Proteolytic enzymes for treatment of wounds and ulcers


Glucocorticoid inhalants for obstructive airway disease


Methyldopa, centrally acting adntiadrenergic agents


Local anesthetics for treatment of hemorrhoids and anal fissures for topical use


Magnesium supplements, alimentary tract and metabolism


ENDOCRINE THERAPY ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS


Pueraria montana var. lobata whole extract


Non-nucleoside reverse transcriptase inhibitors


Bisphosphonate drugs affecting bone structure and mineralization


Thiazolidinediones, blood glucose lowering drugs


Sodium-Glucose Cotransporter 2 Inhibitor [EPC]


Surgical incision wound (morphologic abnormality)


Clostridium difficile infection recurrence


HPV E1/E2 Interaction Inhibitor Gel AP611074


Zirconium Zr 89 Desferrioxamine B Monoclonal Antibody huJ591


Multifunctional/Multitargeted Anticancer Agent OMN54


Liposomal MUC1/PET-lipid A Vaccine ONT-10


Indium In 111 Anti-CD45 Monoclonal Antibody BC8


Multi-epitope Folate Receptor Alpha Peptide Vaccine


HLA-A*2402-Restricted Multipeptide Vaccine S-488410


Saccharomyces boulardii Probiotic Supplement


Anti-TGF-beta RII Monoclonal Antibody IMC-TR1


Recombinant dimeric g-csf fusion protein f627


PEG-3350/Sodium Sulfate/Sodium Chloride/Potassium Chloride/Sodium Ascorbate/Ascorbic Acid-based Laxative


AIDS-Related Human Papillomavirus Infection


Amnion-derived Cellular Cytokine Solution


XBP1-US/XBP1-SP/CD138/CS1 Multipeptide Vaccine PVX-410


Recombinant Human Hsp110-gp100 Chaperone Complex Vaccine


Allogeneic Irradiated Melanoma Cell Vaccine CSF470


ENSAT Stage I Adrenal Cortical Carcinoma


ENSAT Stage II Adrenal Cortical Carcinoma


ENSAT Stage III Adrenal Cortical Carcinoma


Autologous GM-CSF-secreting Lethally Irradiated Leukemia Cell Vaccine


Instiladrin (tradename for Nadofaragene Firadenovec/Syn3)


Cathepsin-Activatable Cy5 Fluorescent Imaging Probe LUM015


low grade serous adenocarcinoma of ovary


Copper Cu 62 Ethylglyoxal Bis(thiosemicarbazone)


Astragalus-based Formulation Qing Shu Yi Qi Tang


tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine, adsorbed


ulcerative oral mucositis due to radiation


Displacement of lumbar intervertebral disc


chronic hypertension complicating pregnancy


B-cell chronic lymphocytic leukemia, in relapse


pyronaridine and artesunate drug combination


Artesunate- and mefloquine-containing product


Sulfonylureas for blood glucose lowering


Corticosteroid derivatives, antimigraine drugs


Corticosteroids for local oral treatment


Dyslipidemia due to type 2 diabetes mellitus


Chronic kidney disease due to type 2 diabetes mellitus


Superficial incisional surgical site infection


Foot ulcer due to type 2 diabetes mellitus


Serum phosphate concentrations above normal (finding)


Dementia due to Alzheimer's disease (disorder)


Serum albumin level decreased below normal (finding)


Parenteral nutrition associated liver disease


Influenza caused by Influenza A virus subtype H7N9


Inflammation of superficial digital flexor tendon of equine limb


pancreatic neoplasm of uncertain behavior somatostatinoma


Cannabis sativa subsp. flowering top extract


Multifocal nodular oncocytic hyperplasia of salivary gland


Hereditary retinal dystrophy primarily involving sensory retina


Chronic paralysis due to lesion of spinal cord


Venous thrombosis due to central venous access device


Proliferative verrucous oral leukoplakia


Hemiplegia and/or hemiparesis following stroke


Cardiorespiratory arrest with successful resuscitation


Chronic obstructive pulmonary disease of horses


Japanese B encephalitis vaccine (product)


Esophageal gastric cardia type metaplasia


Liposome-encapsulated miR-34 Mimic MRX34


Alpha-1,3-galactosyltransferase-expressing Allogeneic Renal Cell Carcinoma Vaccine


Iodine I 124 Phospholipid Ether Analogue CLR1404


Zirconium Zr 89-labeled Monoclonal Antibody MMOT0530A


Liposomal HPV-16 E6/E7 Multipeptide Vaccine PDS0101


Autologous Tumor Cell Proteoliposome Chronic Lymphocytic Leukemia Vaccine


PSMA-targeting Fluorescent Imaging Agent MDX1201-A488


Recombinant Human Adenovirus Type 5 H101


Folate Receptor-Targeted Tubulysin Conjugate EC1456


mRNA-derived Prostate Cancer Vaccine CV9104


Anti-CD27L Antibody-Drug Conjugate AMG 172


Multi-peptide CMV-Modified Vaccinia Ankara Vaccine


Fms/Trk Tyrosine Kinase Inhibitor PLX7486 Tosylate


DLK1/EPHA2/HBB/NRP1/RGS5/TEM1 Peptide-pulsed Alpha-type-1 Polarized Dendritic Cell Vaccine


Adenovirus 5-Human Guanylyl Cyclase C-PADRE Vaccine


intracranial artery occlusion (diagnosis)


Catheter-associated urinary tract infection


Perivascular epithelioid tumor, malignant


Heart failure with reduced ejection fraction


Non-steroidal anti-inflammatory drug-induced enteropathy


Hypoxic ischemic encephalopathy due to cardiac arrest


Acute anterior ST segment elevation myocardial infarction


Malaria in mother complicating childbirth


Small cell carcinoma, hypercalcemic type


Non-small cell lung cancer with mutation in epidermal growth factor receptor


Failed attempted vaginal birth after previous cesarean section


Induced termination of pregnancy in second trimester


Avoidant Restrictive Food Intake Disorder


Tobacco use in mother complicating childbirth


Attention, concentration or memory problems


testosterone 1% Topical Gel, includes 60 ACTUAT Pump, 2500 MG Packet and 5000 MG Packet


Other anti-dementia drug combinations in ATC


Capsaicin 8% patch, per square centimeter


Injection, paclitaxel, 1 mg administered


Blastic plasmacytoid dendritic cell neoplasia


Post transplant Epstein-Barr virus associated lymphoproliferative disorder


lateral epicondylitis of bilateral elbows


Bilateral dermatochalasis of upper eyelids


meningococcal B vaccine, fully recombinant


Infection caused by carbapenem resistant bacteria


Peripheral neuropathy due to and following antineoplastic therapy


Ulcer of foot due to type 1 diabetes mellitus


Allergic asthma caused by Dermatophagoides pteronyssinus


Microalbuminuria due to type 2 diabetes mellitus


Programmed Death Receptor-1 Blocking Antibody


coagulation factor IX (recombinant), glycopegylated


Recombinant Parathyroid Hormone-Related Protein


Metastatic Digestive System Neuroendocrine Tumor G1


Serum-derived Bovine Immunoglobulin Protein Isolate


Multi-epitope Folate Receptor Alpha-loaded Dendritic Cell Vaccine


MAGE-A3-expressing Adenovirus Type 5 Vaccine


Yttrium Y 90-DOTA-di-HSG Peptide IMP-288


Activin Type 2B Receptor Fc Fusion Protein STM 434


Glioma-associated Peptide-loaded Dendritic Cell Vaccine SL-701


Anti-CD70 Antibody-drug Conjugate SGN-CD70A


IDH1R132H-Specific Peptide Vaccine PEPIDH1M


DNA (recombinant human telomerase-specific replication-competent oncolytic adenovirus 5 vector OBP-301)


Anti-gpA33/CD3 Monoclonal Antibody MGD007


Anti-Met/EGFR Monoclonal Antibody LY3164530


Anti c-KIT Antibody-drug Conjugate LOP628


Anti-CEACAM6 AFAIKL2 Antibody Fragment/Jack Bean Urease Immunoconjugate L-DOS47


Dna plasmid encoding interleukin-12 ino-9012


Dendritic Cell-targeting Lentiviral Vector ID-LV305


hTERT Multipeptide/Montanide ISA-51 VG/Imiquimod Vaccine GX 301


Recombinant Anti-WT1 Immunotherapeutic GSK2302024A


hTERT-LAMP mRNA-loaded Autologous Dendritic Cell Vaccine GRNVAC1


PSMA-targeted Tubulysin B-containing Conjugate EC1169


Anti-ETBR/MMAE Antibody-Drug Conjugate DEDN6526A


Anti-mesothelin Antibody-drug Conjugate BMS-986148


Transdermal 17beta-Estradiol Gel BHR-200


Fluorine F 18 L-glutamate Derivative BAY94-9392


Anti-ENPP3/MMAF Antibody-Drug Conjugate AGS-16M8F


Anti-CD19/CD3 Tetravalent Antibody AFM11


Stage IV Primary Peritoneal Cancer AJCC v7


Untreated Childhood Giant Cell Glioblastoma


Untreated Childhood Fibrillary Astrocytoma


Untreated Childhood Anaplastic Oligodendroglioma


Untreated Childhood Anaplastic Astrocytoma


Stage IVC Thyroid Gland Papillary Carcinoma AJCC v7


Stage IVC Thyroid Gland Follicular Carcinoma AJCC v7


Stage IVC Sinonasal Squamous Cell Carcinoma AJCC v7


Stage IVC Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


Stage IVB Thyroid Gland Papillary Carcinoma AJCC v7


Stage IVB Thyroid Gland Follicular Carcinoma AJCC v7


Stage IVB Sinonasal Squamous Cell Carcinoma AJCC v7


Stage IVB Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


Stage IVA Thyroid Gland Papillary Carcinoma AJCC v7


Stage IVA Thyroid Gland Follicular Carcinoma AJCC v7


Stage IVA Sinonasal Squamous Cell Carcinoma AJCC v7


Stage IVA Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


Stage IV Childhood Anaplastic Large Cell Lymphoma


Stage IIIC Primary Peritoneal Cancer AJCC v7


Stage IIIB Primary Peritoneal Cancer AJCC v7


Stage IIIA Primary Peritoneal Cancer AJCC v7


Stage III Primary Peritoneal Cancer AJCC v7


Stage III Childhood Anaplastic Large Cell Lymphoma


Stage II Childhood Anaplastic Large Cell Lymphoma


Stage I Childhood Anaplastic Large Cell Lymphoma


Secondary Central Nervous System Non-Hodgkin Lymphoma


Secondary Central Nervous System Hodgkin Lymphoma


Recurrent Pancreatic Neuroendocrine Carcinoma


Recurrent Malignant Extragonadal Nongerminomatous Germ Cell Tumor


Recurrent Malignant Extragonadal Germ Cell Tumor


Recurrent Childhood Subependymal Giant Cell Astrocytoma


Recurrent Childhood Pilocytic Astrocytoma


Recurrent Childhood Non-Hodgkin Lymphoma


Recurrent Childhood Giant Cell Glioblastoma


Recurrent Childhood Central Nervous System Embryonal Tumor


Recurrent Childhood Anaplastic Oligodendroglioma


Recurrent Childhood Anaplastic Oligoastrocytoma


Recurrent Childhood Anaplastic Large Cell Lymphoma


Recurrent Childhood Anaplastic Astrocytoma


Recurrent Borderline Ovarian Surface Epithelial-Stromal Tumor


Non-Metastatic Childhood Soft Tissue Sarcoma


Cutaneous Melanoma In-Transit Metastasis


Copper Cu 64 Anti-CEA Monoclonal Antibody M5A


Childhood Undifferentiated Pleomorphic Sarcoma


Childhood Favorable Prognosis Hodgkin Lymphoma


Childhood Cerebral Anaplastic Astrocytoma


Childhood Cerebellar Anaplastic Astrocytoma


Childhood Central Nervous System Embryonal Neoplasm


Carbon C 13/Nitrogen N 15-labeled Valine


BCLC Stage D Adult Hepatocellular Carcinoma


BCLC Stage C Adult Hepatocellular Carcinoma


BCLC Stage B Adult Hepatocellular Carcinoma


BCLC Stage A Adult Hepatocellular Carcinoma


BCLC Stage 0 Adult Hepatocellular Carcinoma


Autologous NY-ESO-1-specific CD8-positive T Lymphocytes


Autologous Lymphoma Immunoglobulin-derived scFv-chemokine DNA Vaccine


Adult Unfavorable Prognosis Hodgkin Lymphoma


Adult Favorable Prognosis Hodgkin Lymphoma


Adult B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1


Small cell carcinoma of the ovary, hypercalcemic type


Noonan syndrome-like disorder with juvenile myelomonocytic leukemia


RENAL CELL CARCINOMA, CLEAR CELL, SOMATIC


LEVOMEFOLATE MAGNESIUM 5.23 mg / LEUCOVORIN 2.5 mg / FOLIC ACID 1 mg / FERROUS CYSTEINE GLYCINATE 13.6 mg / MAGNESIUM ASCORBATE 24 mg / ZINC ASCORBATE 1 mg / COCARBOXYLASE 25 ug / FLAVIN ADENINE DINUCLEOTIDE 25 ug / NADH 25 ug / PYRIDOXAL PHOSPHATE ANHYDROUS 25 ug / COBAMAMIDE 50 ug / BETAINE 500 ug / MAGNESIUM L-THREONATE 1 mg / 1,2-DOCOSAHEXANOYL-SN-GLYCERO-3-PHOSPHOSERINE CALCIUM 6.4 mg / 1,2-ICOSAPENTOYL-SN-GLYCERO-3-PHOSPHOSERINE CALCIUM 800 ug / PHOSPHATIDYL SERINE 12 mg ORAL CAPSULE, DELAYED RELEASE PELLETS [EnBrace HR]


Poly(ADP-Ribose) Polymerase Inhibitor [EPC]


herbal medicines bifidobacterium infantis


Asthma-Chronic Obstructive Pulmonary Disease Overlap Syndrome


Bacteremia caused by Methicillin resistant Staphylococcus aureus


Xerostomia due to hyposecretion of salivary gland


hepatitis A virus strain CR 326F antigen, inactivated


Lidocaine Hydrochloride 20 MG/ML includes Injectable Solution, Injection & Prefilled Syringe


Bupivacaine Hydrochloride 2.5 MG/ML includes Injectable Solution and Injection


bupivacaine hydrochloride 7.5 MG/ML Injection


doxycycline 100 MG Oral Tablet includes hyclate & monohydrate salts


Nephrotic Syndrome - Frequently Relapsing


Focal Segmental Glomerulosclerosis, Not Otherwise Specified


Immunotherapeutic Combination Product CMB305


NY-ESO-1-specific TCR Gene-transduced T Lymphocytes TBI-1301


Anti-IL-4/IL-13 Combination Agent QBX258


MAGE-A3-specific Immunotherapeutic GSK 2132231A


WT1 Protein-derived Peptide Vaccine DSP-7888


Anti-human Cytomegalovirus Monoclonal Antibody Combination CSJ-148


Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone


Adult Undifferentiated High Grade Pleomorphic Sarcoma of Bone


Refractory Childhood Malignant Germ Cell Tumor


Refractory Childhood Acute Lymphoblastic Leukemia


B Acute Lymphoblastic Leukemia, BCR-ABL1-Like


Localized Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone


Localized Adult Undifferentiated High Grade Pleomorphic Sarcoma of Bone


Anti-CD20 B9E9 scFv-Streptavidin Fusion Protein


Anti-CD122 Humanized Monoclonal Antibody Mik-Beta-1


fragile x associated tremor/ataxia syndrome (FXTAS)


Current smoker (e.g., cigarette, cigar, pipe, e-cigarette or marijuana)


Chronic kidney disease stage 5 on dialysis


Acute kidney injury caused by contrast agent


primary invasive malignant neoplasm of female breast


Acute graft-versus-host reaction following bone marrow transplant


Anti-OX40 Monoclonal Antibody GSK3174998


Anti-pd-1 checkpoint inhibitor pf-06801591


Bendamustine-containing Nanoparticle-based Formulation RXDX-107


Childhood Central Nervous System Ganglioneuroblastoma


Childhood Gastrointestinal Stromal Tumor


Intrachromosomal Amplification of Chromosome 21


Substance with programmed cell death protein 1 inhibitor mechanism of action (substance)


Recurrent Acute Myeloid Leukemia with Myelodysplasia-Related Changes


Spleen Tyrosine Kinase Inhibitor HMPL-523


Neuromyelitis optica spectrum disorder relapse


Central sleep apnea comorbid with opioid use


Childhood-onset fluency disorder (stuttering)


Gender dysphoria in adolescents and adults


Gastrointestinal stromal tumor of rectum


Generalized severe chronic periodontitis


irritable bowel syndrome with constipation


Benign prostatic hyperplasia with lower urinary tract symptoms


type 2 diabetes mellitus with diabetic macular edema


type 1 diabetes with diabetic macular edema


idiopathic mast cell activation disorder


Severe acute respiratory syndrome of upper respiratory tract


SOYBEAN OIL 6 g in 100 mL / MEDIUM-CHAIN TRIGLYCERIDES 6 g in 100 mL / OLIVE OIL 5 g in 100 mL / FISH OIL 3 g in 100 mL INTRAVENOUS INJECTION, EMULSION


Transcription Activator-Like Effector Nucleases


Reduced ejection fraction co-occurrent and due to chronic heart failure


Marcaine 0.5% includes Injection and Injectable Solution


Choline c-11, diagnostic, per study dose up to 20 millicuries


Fluciclovine f-18, diagnostic, 1 millicurie


Neutrophil Activation Probe Imaging Agent


Severe Fever with Thrombocytopenia Syndrome


Absorbable Modified Polymer Hemostatic Powder


Neuroendocrine tumour of the lung metastatic


Behavioral and psychological symptoms of dementia


Obstructive sleep apnea hypopnea syndrome


Quadrivalent Inactivated Influenza Vaccine


Factor VII-targeting Immunoconjugate Protein ICON-1


Anti-LAMP1 Antibody-drug Conjugate SAR428926


Microparticle MDP/Bacterial DNA-containing MIS416


Anti-CD123/CD3 Bispecific Antibody JNJ-63709178


HLA-A2-restricted Melanoma-specific Peptides Vaccine GRN-1201


Autologous Prostate Stem Cell Antigen-specific CAR T Cells BPX-601


pUMVC3-IGFBP2-HER2-IGF1R Plasmid DNA Vaccine


Refractory Adult Acute Lymphoblastic Leukemia


Recurrent Lung Non-Squamous Non-Small Cell Carcinoma


Primary Peritoneal Low Grade Serous Adenocarcinoma


Primary Peritoneal High Grade Serous Adenocarcinoma


Oropharyngeal Basaloid Squamous Cell Carcinoma


Metastatic Lung Non-Squamous Non-Small Cell Carcinoma


Low Grade Fallopian Tube Serous Adenocarcinoma


Fallopian Tube High Grade Serous Adenocarcinoma


Glioblastoma with Primitive Neuronal Component


Chronic Active EBV Infection of T-and NK-Cell Type, Systemic Form


Bacillus calmette-guerin substrain tokyo 172-1 live antigen


B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative


pre-eclampsia superimposed pre-existing hypertension


(SPL REVIEW) Clobetasol Propionate .05 mg in 100 mL TOPICAL LOTION


non-ischemic central retinal vein occlusion with macular edema


Neuroendocrine tumor G1 (NET G1)/Carcinoid


Primary squamous cell carcinoma of anal canal


Reactive oxygen species 1 positive non-small cell lung cancer


Acute kidney injury due to circulatory failure


Non-erosive gastro-esophageal reflux disease


Recombinant human alpha 1-antitrypsin (raat)


Acute severe refractory exacerbation of asthma


Constitutional Mismatch Repair Deficiency Syndrome


Cystic fibrosis gastrointestinal disease


Chemotherapy induced systolic dysfunction


Cardiomyopathy secondary to doxorubicin administration


AXL Receptor Tyrosine Kinase/cMET Inhibitor BPI-9016M


Adenovirus-expressing TLR5/TLR5 Agonist Nanoformulation M-VM3


Albumin-binding Cisplatin Prodrug BTP-114


Anti-CD123-Pyrrolobenzodiazepine Dimer Antibody Drug Conjugate SGN-CD123A


Anti-CD352 Antibody-drug Conjugate SGN-CD352A


Anti-CD73 Monoclonal Antibody BMS-986179


Anti-CDH6 Antibody-drug Conjugate HKT288


Anti-CSF1 Monoclonal Antibody PD-0360324


Anti-EGFR/HER2/HER3 Monoclonal Antibody Mixture Sym013


Anti-GITR Agonistic Monoclonal Antibody BMS-986156


Anti-Glypican 3/CD3 Bispecific Antibody ERY974


Anti-human GITR Monoclonal Antibody AMG 228


Central Nervous System Embryonal Tumor with Rhabdoid Features


Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8


Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8


Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8


Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8


HPV Types 16/18 E6/E7-Adenoviral Transduced Autologous Lymphocytes/alpha-Galactosylceramide Vaccine BVAC-C


HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma by AJCC v8 Clinical Stage


HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma by AJCC v8 Pathologic Stage


HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma by AJCC v8 Stage


Burkitt-like lymphoma with 11q aberration


Medulloblastoma, Not Otherwise Specified


Prostate Carcinoma Metastatic in the Soft Tissue


Multiple TAA-loaded Dendritic Cell Vaccine


Pathologic Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8


Pathologic Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8


Pathologic Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8


Personalized Peptide Cancer Vaccine NEO-PV-01


Human Recombinant Bone Morphogenetic Protein 4


Recurrent Childhood T Acute Lymphoblastic Leukemia


Recurrent Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma


Recurrent Endometrial Serous Adenocarcinoma


Resectable Head and Neck Squamous Cell Carcinoma


SSTR2-targeting Protein/DM1 Conjugate PEN-221


Stage 0 Oropharyngeal (p16-Negative) Carcinoma AJCC v8


Stage I Hypopharyngeal Carcinoma AJCC v8


Stage I Lip and Oral Cavity Cancer AJCC v8


Stage I Nasopharyngeal Carcinoma AJCC v8


Stage I Oropharyngeal (p16-Negative) Carcinoma AJCC v8


Stage II Hypopharyngeal Carcinoma AJCC v8


Stage II Lip and Oral Cavity Cancer AJCC v8


Stage II Nasopharyngeal Carcinoma AJCC v8


Stage II Oropharyngeal (p16-Negative) Carcinoma AJCC v8


Stage III Hypopharyngeal Carcinoma AJCC v8


Stage III Lip and Oral Cavity Cancer AJCC v8


Stage III Major Salivary Gland Cancer AJCC v8


Stage III Nasopharyngeal Carcinoma AJCC v8


Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8


Stage IV Hypopharyngeal Carcinoma AJCC v8


Stage IV Lip and Oral Cavity Cancer AJCC v8


Stage IV Nasopharyngeal Carcinoma AJCC v8


Stage IV Oropharyngeal (p16-Negative) Carcinoma AJCC v8


Stage IVA Hypopharyngeal Carcinoma AJCC v8


Stage IVA Lip and Oral Cavity Cancer AJCC v8


Stage IVA Major Salivary Gland Cancer AJCC v8


Stage IVA Nasopharyngeal Carcinoma AJCC v8


Stage IVB Hypopharyngeal Carcinoma AJCC v8


Stage IVB Lip and Oral Cavity Cancer AJCC v8


Stage IVB Major Salivary Gland Cancer AJCC v8


Stage IVB Nasopharyngeal Carcinoma AJCC v8


Stage IVC Hypopharyngeal Carcinoma AJCC v8


Stage IVC Lip and Oral Cavity Cancer AJCC v8


Stage IVC Oropharyngeal (p16-Negative) Carcinoma AJCC v8


Sustained-Exposure Dexamethasone Formulation OTO-104


Traditional Chinese Medicine Formulation


Unresectable Digestive System Adenocarcinoma


Unresectable Transitional Cell Carcinoma


Recombinant Vesicular Stomatitis Virus-expressing Human Interferon Beta and Sodium-Iodide Symporter


Agonistic Anti-OX40 Monoclonal Antibody INCAGN01949


Nasopharyngeal Carcinoma by AJCC v8 Stage


Stage IV Major Salivary Gland Cancer AJCC v8


Stage IVC Major Salivary Gland Cancer AJCC v8


Pathologic Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8


Stage IVA Oropharyngeal (p16-Negative) Carcinoma AJCC v8


Stage IVB Oropharyngeal (p16-Negative) Carcinoma AJCC v8


DiaResQ Children's Powder for Suspension


adverse effect of drugs and medicaments in therapeutic use


Intranasal Live-Attenuated Influenza Vaccine


gastric inhibitory polypeptide (3-30)-amide


Blastic plasmacytoid dendritic cell neoplasm (BPDCN)


Transthyretin-related (ATTR) familial amyloid polyneuropathy


pulmonary hypertension due to lung diseases and hypoxia


Transthyretin-related (ATTR) familial amyloid cardiomyopathy


Arthritis of first carpometacarpal joint of left hand


Arthritis of first carpometacarpal joint of right hand


Insomnia co-occurrent and due to medical condition


Negative symptoms co-occurrent and due to primary psychotic disorder


Glioblastoma isocitrate dehydrogenase wildtype


Pulmonary myxoid sarcoma with EWSR1-CREB1 translocation


Anaplastic lymphoma kinase positive anaplastic large cell lymphoma


Major depression with psychotic features


Primary mucinous adenocarcinoma of ovary


Bacillus calmette-guerin substrain danish 1331 live antigen


Stage IIIA Anal Canal Cancer AJCC v6 and v7


Stage IIIB Anal Canal Cancer AJCC v6 and v7


Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma


Stage I Adult Soft Tissue Sarcoma AJCC v7


Stage II Adult Soft Tissue Sarcoma AJCC v7


Stage III Adult Soft Tissue Sarcoma AJCC v7


Stage IV Adult Soft Tissue Sarcoma AJCC v7


Stage I Childhood Hepatocellular Carcinoma AJCC v6 and v7


Stage IV Childhood Hepatocellular Carcinoma AJCC v7


Stage II Cutaneous Melanoma AJCC v6 and v7


Stage IV Cutaneous Melanoma AJCC v6 and v7


Stage 0 Non-Small Cell Lung Cancer AJCC v6 and v7


Stage I Major Salivary Gland Cancer AJCC v7


Stage II Major Salivary Gland Cancer AJCC v7


Stage III Major Salivary Gland Cancer AJCC v7


Stage IV Major Salivary Gland Cancer AJCC v7


Stage I Laryngeal Squamous Cell Carcinoma AJCC v6 and v7


Stage I Laryngeal Verrucous Carcinoma AJCC v6 and v7


Stage II Laryngeal Squamous Cell Carcinoma AJCC v6 and v7


Stage II Laryngeal Verrucous Carcinoma AJCC v6 and v7


Stage III Laryngeal Squamous Cell Carcinoma AJCC v6 and v7


Stage III Laryngeal Verrucous Carcinoma AJCC v6 and v7


Stage III Sinonasal Squamous Cell Carcinoma AJCC v6 and v7


Stage 0 Cutaneous Melanoma AJCC v6 and v7


Factor viii (antihemophilic factor, human) per i.u.


Stage IV Anal Canal Cancer AJCC v6 and v7


Stage IIB Adult Soft Tissue Sarcoma AJCC v7


Stage I Pancreatic Cancer AJCC v6 and v7


Stage II Pancreatic Cancer AJCC v6 and v7


Stage III Pancreatic Cancer AJCC v6 and v7


Stage IV Pancreatic Cancer AJCC v6 and v7


Stage III Nasopharyngeal Carcinoma AJCC v7


Myocardial infarction due to demand ischemia


Substance with proprotein convertase subtilisin/kexin type 9 inhibitor mechanism of action


Stage III Pleural Malignant Mesothelioma AJCC v8


Stage IV Pleural Malignant Mesothelioma AJCC v8


Stage II Nasal Cavity and Paranasal Sinus Cancer AJCC v8


Stage III Nasal Cavity and Paranasal Sinus Cancer AJCC v8


Stage IV Nasal Cavity and Paranasal Sinus Cancer AJCC v8


Stage IVA Nasal Cavity and Paranasal Sinus Cancer AJCC v8


Stage IVB Nasal Cavity and Paranasal Sinus Cancer AJCC v8


Clinical Stage I Esophageal Adenocarcinoma AJCC v8


Clinical Stage II Esophageal Adenocarcinoma AJCC v8


Clinical Stage IIA Esophageal Adenocarcinoma AJCC v8


Clinical Stage IIB Esophageal Adenocarcinoma AJCC v8


Clinical Stage III Esophageal Adenocarcinoma AJCC v8


Clinical Stage IV Esophageal Adenocarcinoma AJCC v8


Clinical Stage IVA Esophageal Adenocarcinoma AJCC v8


Clinical Stage IVB Esophageal Adenocarcinoma AJCC v8


Pathologic Stage IB Esophageal Adenocarcinoma AJCC v8


Pathologic Stage II Esophageal Adenocarcinoma AJCC v8


Pathologic Stage IIA Esophageal Adenocarcinoma AJCC v8


Pathologic Stage IIB Esophageal Adenocarcinoma AJCC v8


Pathologic Stage III Esophageal Adenocarcinoma AJCC v8


Pathologic Stage IIIA Esophageal Adenocarcinoma AJCC v8


Pathologic Stage IIIB Esophageal Adenocarcinoma AJCC v8


Pathologic Stage IV Esophageal Adenocarcinoma AJCC v8


Pathologic Stage IVA Esophageal Adenocarcinoma AJCC v8


Pathologic Stage IVB Esophageal Adenocarcinoma AJCC v8


Postneoadjuvant Therapy Stage II Esophageal Adenocarcinoma AJCC v8


Postneoadjuvant Therapy Stage III Esophageal Adenocarcinoma AJCC v8


Postneoadjuvant Therapy Stage IIIA Esophageal Adenocarcinoma AJCC v8


Postneoadjuvant Therapy Stage IIIB Esophageal Adenocarcinoma AJCC v8


Postneoadjuvant Therapy Stage IV Esophageal Adenocarcinoma AJCC v8


Postneoadjuvant Therapy Stage IVA Esophageal Adenocarcinoma AJCC v8


Postneoadjuvant Therapy Stage IVB Esophageal Adenocarcinoma AJCC v8


Clinical Stage II Esophageal Squamous Cell Carcinoma AJCC v8


Clinical Stage III Esophageal Squamous Cell Carcinoma AJCC v8


Clinical Stage IV Esophageal Squamous Cell Carcinoma AJCC v8


Clinical Stage IVA Esophageal Squamous Cell Carcinoma AJCC v8


Clinical Stage IVB Esophageal Squamous Cell Carcinoma AJCC v8


Postneoadjuvant Therapy Stage III Esophageal Squamous Cell Carcinoma AJCC v8


Postneoadjuvant Therapy Stage IIIA Esophageal Squamous Cell Carcinoma AJCC v8


Postneoadjuvant Therapy Stage IIIB Esophageal Squamous Cell Carcinoma AJCC v8


Postneoadjuvant Therapy Stage IV Esophageal Squamous Cell Carcinoma AJCC v8


Postneoadjuvant Therapy Stage IVA Esophageal Squamous Cell Carcinoma AJCC v8


Postneoadjuvant Therapy Stage IVB Esophageal Squamous Cell Carcinoma AJCC v8


Pathologic Stage III Esophageal Squamous Cell Carcinoma AJCC v8


Pathologic Stage IIIA Esophageal Squamous Cell Carcinoma AJCC v8


Pathologic Stage IIIB Esophageal Squamous Cell Carcinoma AJCC v8


Pathologic Stage IV Esophageal Squamous Cell Carcinoma AJCC v8


Pathologic Stage IVA Esophageal Squamous Cell Carcinoma AJCC v8


Pathologic Stage IVB Esophageal Squamous Cell Carcinoma AJCC v8


Clinical Stage II Gastric Cancer AJCC v8


Clinical Stage III Gastric Cancer AJCC v8


Clinical Stage IV Gastric Cancer AJCC v8


Pathologic Stage 0 Gastric Cancer AJCC v8


Hypersensitivity reaction caused by food


Pathologic Stage I Gastric Cancer AJCC v8


Pathologic Stage IA Gastric Cancer AJCC v8


Pathologic Stage IB Gastric Cancer AJCC v8


Pathologic Stage II Gastric Cancer AJCC v8


Pathologic Stage IIA Gastric Cancer AJCC v8


Pathologic Stage IIB Gastric Cancer AJCC v8


Pathologic Stage III Gastric Cancer AJCC v8


Pathologic Stage IIIA Gastric Cancer AJCC v8


Pathologic Stage IIIB Gastric Cancer AJCC v8


Pathologic Stage IIIC Gastric Cancer AJCC v8


Pathologic Stage IV Gastric Cancer AJCC v8


Postneoadjuvant Therapy Stage I Gastric Cancer AJCC v8


Postneoadjuvant Therapy Stage II Gastric Cancer AJCC v8


Postneoadjuvant Therapy Stage III Gastric Cancer AJCC v8


Postneoadjuvant Therapy Stage IV Gastric Cancer AJCC v8


Clinical Stage IIA Gastric Cancer AJCC v8


Clinical Stage IIB Gastric Cancer AJCC v8


Stage IIIA Hilar Cholangiocarcinoma AJCC v8


Stage IIIB Hilar Cholangiocarcinoma AJCC v8


Stage IVA Hilar Cholangiocarcinoma AJCC v8


Stage IVB Hilar Cholangiocarcinoma AJCC v8


Stage III Distal Bile Duct Cancer AJCC v8


Stage IV Distal Bile Duct Cancer AJCC v8


Stage III Ampulla of Vater Cancer AJCC v8


Stage IV Ampulla of Vater Cancer AJCC v8


Stage IA Pleural Malignant Mesothelioma AJCC v7


Stage IB Pleural Malignant Mesothelioma AJCC v7


Stage IV Hepatocellular Carcinoma AJCC v7


Stage III Hepatocellular Carcinoma AJCC v7


C-MYC/BCL6 double-hit high-grade B-cell lymphoma


C-MYC/BCL2 double-hit high-grade B-cell lymphoma


Locally Advanced Malignant Solid Neoplasm


Fluorine F 18 Integrin Alpha v Beta 6-targeted Peptide


Astatine At 211 Anti-CD45 Monoclonal Antibody BC8-B10


Cutaneous Squamous Cell Carcinoma of the Head and Neck


Stage 0 Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8


Stage I Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8


Stage II Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8


Stage III Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8


Stage IV Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8


Pathologic Stage IC Esophageal Adenocarcinoma AJCC v8


Esophageal Squamous Cell Carcinoma by AJCC v8 Stage


Large B-cell lymphoma with IRF4 rearrangement


Clinical Stage 0 Gastroesophageal Junction Adenocarcinoma AJCC v8


Clinical Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8


Clinical Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8


Clinical Stage IIA Gastroesophageal Junction Adenocarcinoma AJCC v8


Clinical Stage IIB Gastroesophageal Junction Adenocarcinoma AJCC v8


Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8


Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8


Clinical Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8


Clinical Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8


Pathologic Stage 0 Gastroesophageal Junction Adenocarcinoma AJCC v8


Pathologic Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8


Pathologic Stage IA Gastroesophageal Junction Adenocarcinoma AJCC v8


Pathologic Stage IB Gastroesophageal Junction Adenocarcinoma AJCC v8


Pathologic Stage IC Gastroesophageal Junction Adenocarcinoma AJCC v8


Pathologic Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8


Pathologic Stage IIA Gastroesophageal Junction Adenocarcinoma AJCC v8


Pathologic Stage IIB Gastroesophageal Junction Adenocarcinoma AJCC v8


Pathologic Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8


Pathologic Stage IIIA Gastroesophageal Junction Adenocarcinoma AJCC v8


Pathologic Stage IIIB Gastroesophageal Junction Adenocarcinoma AJCC v8


Pathologic Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8


Pathologic Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8


Pathologic Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8


Postneoadjuvant Therapy Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8


Postneoadjuvant Therapy Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8


Postneoadjuvant Therapy Stage IIIA Gastroesophageal Junction Adenocarcinoma AJCC v8


Postneoadjuvant Therapy Stage IIIB Gastroesophageal Junction Adenocarcinoma AJCC v8


Postneoadjuvant Therapy Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8


Postneoadjuvant Therapy Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8


Postneoadjuvant Therapy Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8


Clinical Stage IVA Gastric Cancer AJCC v8


Clinical Stage IVB Gastric Cancer AJCC v8


Homologous Recombination Repair Gene Mutation


Squamous cell carcinoma of head and neck recurrent


Anti-AG7 Antibody Drug Conjugate AbGn-107


Stage III Small Intestinal Adenocarcinoma AJCC v8


Stage IIIA Small Intestinal Adenocarcinoma AJCC v8


Stage IIIB Small Intestinal Adenocarcinoma AJCC v8


Stage IV Small Intestinal Adenocarcinoma AJCC v8


Refractory Histiocytic and Dendritic Cell Neoplasm


Recurrent Histiocytic and Dendritic Cell Neoplasm


Refractory Langerhans Cell Histiocytosis


Stage I Hepatocellular Carcinoma AJCC v8


Stage IA Hepatocellular Carcinoma AJCC v8


Stage IB Hepatocellular Carcinoma AJCC v8


Stage III Hepatocellular Carcinoma AJCC v8


Stage IIIA Hepatocellular Carcinoma AJCC v8


Stage IIIB Hepatocellular Carcinoma AJCC v8


Stage IV Hepatocellular Carcinoma AJCC v8


Stage IVA Hepatocellular Carcinoma AJCC v8


Stage IVB Hepatocellular Carcinoma AJCC v8


Stage III Intrahepatic Bile Duct Cancer AJCC v8


Stage IIIA Intrahepatic Bile Duct Cancer AJCC v8


Stage IIIB Intrahepatic Bile Duct Cancer AJCC v8


Stage IV Intrahepatic Bile Duct Cancer AJCC v8


Stage III Hilar Cholangiocarcinoma AJCC v8


Stage IV Hilar Cholangiocarcinoma AJCC v8


Stage 0 Intrahepatic Cholangiocarcinoma AJCC v8


Stage I Intrahepatic Cholangiocarcinoma AJCC v8


Stage IB Intrahepatic Cholangiocarcinoma AJCC v8


Stage II Intrahepatic Cholangiocarcinoma AJCC v8


Stage III Intrahepatic Cholangiocarcinoma AJCC v8


Stage IIIB Intrahepatic Cholangiocarcinoma AJCC v8


Stage IV Intrahepatic Cholangiocarcinoma AJCC v8


Stage IIIA Distal Bile Duct Cancer AJCC v8


Stage IIIB Distal Bile Duct Cancer AJCC v8


Recurrent B Acute Lymphoblastic Leukemia, BCR-ABL1-Like


Refractory B Acute Lymphoblastic Leukemia, BCR-ABL1-Like


Stage IIIA Ampulla of Vater Cancer AJCC v8


Stage IIIB Ampulla of Vater Cancer AJCC v8


Stage I Pancreatic Neuroendocrine Tumor AJCC v8


Stage II Pancreatic Neuroendocrine Tumor AJCC v8


Stage III Pancreatic Neuroendocrine Tumor AJCC v8


Stage IV Pancreatic Neuroendocrine Tumor AJCC v8


Anti-CTLA4 Monoclonal Antibody BMS-986218


Anti-GD3 Antibody-drug Conjugate PF-06688992


Unresectable Head and Neck Squamous Cell Carcinoma


Cisplatin/Vinblastine/Cell Penetration Enhancer Formulation INT230-6


Recurrent Diffuse Intrinsic Pontine Glioma


Refractory Diffuse Intrinsic Pontine Glioma


Stage I Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8


Stage IA Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8


Stage IB Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8


Stage II Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8


Stage III Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8


Stage IIIA Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8


Stage IIIB Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8


Stage IV Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8


Stage III Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8


Stage IV Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8


Anti-RNF43 Antibody-drug Conjugate SC-006


Stage III Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor AJCC v8


Stage IV Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor AJCC v8


Stage IA Retroperitoneal Sarcoma AJCC v8


Stage IB Retroperitoneal Sarcoma AJCC v8


Stage II Retroperitoneal Sarcoma AJCC v8


Stage III Retroperitoneal Sarcoma AJCC v8


Stage IIIA Retroperitoneal Sarcoma AJCC v8


Stage IIIB Retroperitoneal Sarcoma AJCC v8


Stage IV Retroperitoneal Sarcoma AJCC v8


Clinical Stage III Cutaneous Merkel Cell Carcinoma AJCC v8


Clinical Stage IV Cutaneous Merkel Cell Carcinoma AJCC v8


Pathologic Stage I Cutaneous Merkel Cell Carcinoma AJCC v8


Pathologic Stage II Cutaneous Merkel Cell Carcinoma AJCC v8


Pathologic Stage III Cutaneous Merkel Cell Carcinoma AJCC v8


Pathologic Stage IIIB Merkel Cell Carcinoma AJCC v8


Pathologic Stage IV Cutaneous Merkel Cell Carcinoma AJCC v8


Anti-EphA2 Antibody-directed Liposomal Docetaxel Prodrug MM-310


Clinical Stage 0 Cutaneous Melanoma AJCC v8


Clinical Stage I Cutaneous Melanoma AJCC v8


Clinical Stage IA Cutaneous Melanoma AJCC v8


Clinical Stage IB Cutaneous Melanoma AJCC v8


Clinical Stage II Cutaneous Melanoma AJCC v8


Clinical Stage IIA Cutaneous Melanoma AJCC v8


Clinical Stage IIB Cutaneous Melanoma AJCC v8


Clinical Stage IIC Cutaneous Melanoma AJCC v8


Clinical Stage III Cutaneous Melanoma AJCC v8


Clinical Stage IV Cutaneous Melanoma AJCC v8


Pathologic Stage 0 Cutaneous Melanoma AJCC v8


Pathologic Stage I Cutaneous Melanoma AJCC v8


Pathologic Stage IA Cutaneous Melanoma AJCC v8


Pathologic Stage IB Cutaneous Melanoma AJCC v8


Pathologic Stage II Cutaneous Melanoma AJCC v8


Pathologic Stage IIA Cutaneous Melanoma AJCC v8


Pathologic Stage IIB Cutaneous Melanoma AJCC v8


Pathologic Stage IIC Cutaneous Melanoma AJCC v8


Pathologic Stage III Cutaneous Melanoma AJCC v8


Pathologic Stage IIIA Cutaneous Melanoma AJCC v8


Pathologic Stage IIIB Cutaneous Melanoma AJCC v8


Pathologic Stage IIIC Cutaneous Melanoma AJCC v8


Pathologic Stage IIID Cutaneous Melanoma AJCC v8


Pathologic Stage IV Cutaneous Melanoma AJCC v8


Anti-ASCT2 Antibody-drug Conjugate MEDI7247


Refractory Pancreatic Neuroendocrine Carcinoma


Human papillomavirus virus-like particles conjugated with ir700 dye au-011


Recurrent Central Nervous System Lymphoma


Refractory Central Nervous System Lymphoma


Recurrent Intravascular Large B-Cell Lymphoma


Refractory Intravascular Large B-Cell Lymphoma


Recurrent Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type


Refractory Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type


HHV8-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified


Recurrent High Risk Myelodysplastic Syndrome


Indolent T-cell lymphoproliferative disorder of gastrointestinal tract


Primary cutaneous acral CD8 positive T-cell lymphoma


Florid Follicular Hyperplasia Post-Transplant Lymphoproliferative Disorder


Advanced Head and Neck Squamous Cell Carcinoma


Anatomic Stage IIA Breast Cancer AJCC v8


Anatomic Stage IIB Breast Cancer AJCC v8


Anatomic Stage III Breast Cancer AJCC v8


Anatomic Stage IIIA Breast Cancer AJCC v8


Anatomic Stage IIIB Breast Cancer AJCC v8


Anatomic Stage IIIC Breast Cancer AJCC v8


Prognostic Stage 0 Breast Cancer AJCC v8


Prognostic Stage I Breast Cancer AJCC v8


Prognostic Stage IA Breast Cancer AJCC v8


Prognostic Stage IB Breast Cancer AJCC v8


Malignant Neoplasm of Lung - Multiple Primary Sites


Prognostic Stage II Breast Cancer AJCC v8


Prognostic Stage IIA Breast Cancer AJCC v8


Prognostic Stage IIB Breast Cancer AJCC v8


Prognostic Stage III Breast Cancer AJCC v8


Prognostic Stage IIIA Breast Cancer AJCC v8


Prognostic Stage IIIB Breast Cancer AJCC v8


Prognostic Stage IIIC Breast Cancer AJCC v8


Prognostic Stage IV Breast Cancer AJCC v8


Stage III Acral Lentiginous Melanoma AJCC v7


Stage IV Acral Lentiginous Melanoma AJCC v6 and v7


Stage II Hepatocellular Carcinoma AJCC v8


Pathologic Stage IIIA Merkel Cell Carcinoma AJCC v8


Refractory High Risk Myelodysplastic Syndrome


Recurrent Atypical Teratoid/Rhabdoid Tumor


Stage IIIA Intrahepatic Cholangiocarcinoma AJCC v8


varicella zoster virus glycoprotein E, recombinant


Acute lung injury/Acute respiratory distress syndrome (ARDS)


Coronary artery disease (CAD) (e.g., angina, myocardial infarction, and atherosclerotic heart disease (ASHD))


type 2 diabetes mellitus with proteinuria


Microsatellite instability-high solid malignant tumor


Lactic acidosis due to diabetes mellitus


Dissociative neurological symptom disorder (disorder)


Microsatellite instability-high colorectal cancer


Interstitial lung disease due to systemic disease


Stage IVA Cervical Cancer AJCC v6 and v7


Stage III Testicular Cancer AJCC v6 and v7


Stage III Cervical Cancer AJCC v6 and v7


Stage IIB Cervical Cancer AJCC v6 and v7


Stage IVB Cervical Cancer AJCC v6 and v7


Thymidine Kinase (-) Vaccinia-GM-CSF JX-594 Vaccine


Polyarthritis, Juvenile, Rheumatoid Factor Negative


Product containing only doxycycline 100 mg/1 each oral tablet


Acute bacterial skin and skin structure infection


Stage I Renal Pelvis and Ureter Cancer AJCC v8


Stage II Renal Pelvis and Ureter Cancer AJCC v8


Stage III Adrenal Cortex Carcinoma AJCC v8


Stage III Differentiated Thyroid Gland Carcinoma AJCC v8


Stage III Primary Peritoneal Cancer AJCC v8


Stage III Renal Pelvis and Ureter Cancer AJCC v8


Stage III Thyroid Gland Follicular Carcinoma AJCC v8


Stage III Thyroid Gland Medullary Carcinoma AJCC v8


Stage III Thyroid Gland Papillary Carcinoma AJCC v8


Stage IIIB Fallopian Tube Cancer AJCC v8


Stage IIIB Primary Peritoneal Cancer AJCC v8


Stage IIIB Uterine Corpus Cancer AJCC v8


Stage IIIA Fallopian Tube Cancer AJCC v8


Stage IIIA Primary Peritoneal Cancer AJCC v8


Stage IIIA Uterine Corpus Cancer AJCC v8


Stage IIIC Uterine Corpus Cancer AJCC v8


Stage IIIC1 Uterine Corpus Cancer AJCC v8


Stage IIIC2 Uterine Corpus Cancer AJCC v8


Stage IIIC Fallopian Tube Cancer AJCC v8


Stage IIIC Primary Peritoneal Cancer AJCC v8


Stage IV Adrenal Cortex Carcinoma AJCC v8


Stage IV Primary Peritoneal Cancer AJCC v8


Stage 0a Renal Pelvis and Ureter Cancer AJCC v8


Stage 0is Renal Pelvis and Ureter Cancer AJCC v8


Stage IV Renal Pelvis and Ureter Cancer AJCC v8


Stage IV Thyroid Gland Follicular Carcinoma AJCC v8


Stage IV Thyroid Gland Medullary Carcinoma AJCC v8


Stage IV Thyroid Gland Papillary Carcinoma AJCC v8


Stage IVA Differentiated Thyroid Gland Carcinoma AJCC v8


Stage IVB Differentiated Thyroid Gland Carcinoma AJCC v8


Stage IVA Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v8


Stage IVB Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v8


Stage IVC Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v8


Stage IVA Thyroid Gland Medullary Carcinoma AJCC v8


Stage IVB Thyroid Gland Medullary Carcinoma AJCC v8


Stage IVC Thyroid Gland Medullary Carcinoma AJCC v8


Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma


Trastuzumab/Tesirine Antibody-drug Conjugate ADCT-502


Stage III Uterine Corpus Leiomyosarcoma AJCC v8


Stage IIIA Uterine Corpus Leiomyosarcoma AJCC v8


Stage IIIB Uterine Corpus Leiomyosarcoma AJCC v8


Stage IIIC Uterine Corpus Leiomyosarcoma AJCC v8


Stage IV Uterine Corpus Leiomyosarcoma AJCC v8


Stage IVA Uterine Corpus Leiomyosarcoma AJCC v8


Stage IVB Uterine Corpus Leiomyosarcoma AJCC v8


Stage IIIA1 Fallopian Tube Cancer AJCC v8


Stage IIIA2 Fallopian Tube Cancer AJCC v8


Stage II Primary Peritoneal Cancer AJCC v8


Stage IIA Primary Peritoneal Cancer AJCC v8


Stage IIB Primary Peritoneal Cancer AJCC v8


Stage IVA Primary Peritoneal Cancer AJCC v8


Stage IVB Primary Peritoneal Cancer AJCC v8


Refractory Transformed Non-Hodgkin Lymphoma


Testicular Cancer by AJCC v6 and v7 Stage


Metastatic Non-Functioning Neuroendocrine Tumor


Selective Estrogen Receptor Degrader SAR439859


Stage IV Choroidal and Ciliary Body Melanoma AJCC v8


Stage IV Differentiated Thyroid Gland Carcinoma AJCC v8


Thyroid Gland Anaplastic Carcinoma by AJCC v8 Stage


Recurrent Extensive Stage Lung Small Cell Carcinoma


Refractory Extensive Stage Lung Small Cell Carcinoma


Stage III Adrenal Gland Pheochromocytoma and Sympathetic Paraganglioma AJCC v8


Stage IV Adrenal Gland Pheochromocytoma and Sympathetic Paraganglioma AJCC v8


Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8


Lugano Classification Stage III Hodgkin Lymphoma AJCC v8


Lugano Classification Stage IV Hodgkin Lymphoma AJCC v8


Chronic Lymphocytic Leukemia- Binet Staging System


Stage IB Mycosis Fungoides and Sezary Syndrome AJCC v8


Stage II Mycosis Fungoides and Sezary Syndrome AJCC v8


Stage IIA Mycosis Fungoides and Sezary Syndrome AJCC v8


Stage IIB Mycosis Fungoides and Sezary Syndrome AJCC v8


Stage III Mycosis Fungoides and Sezary Syndrome AJCC v8


Stage IIIA Mycosis Fungoides and Sezary Syndrome AJCC v8


Stage IIIB Mycosis Fungoides and Sezary Syndrome AJCC v8


Stage IV Mycosis Fungoides and Sezary Syndrome AJCC v8


Stage IVA1 Mycosis Fungoides and Sezary Syndrome AJCC v8


Stage IVA2 Mycosis Fungoides and Sezary Syndrome AJCC v8


Stage IVB Mycosis Fungoides and Sezary Syndrome AJCC v8


Lipid Nanoparticle Encapsulated OX40L mRNA-2416


Recurrent B Acute Lymphoblastic Leukemia


Refractory B Acute Lymphoblastic Leukemia


Anti-Caprin-1 Monoclonal Antibody TRK-950


Methionine Aminopeptidase 2 Inhibitor M8891


Refractory Peripheral Primitive Neuroectodermal Tumor


Metastatic Microsatellite Stable Colorectal Carcinoma


Advanced Microsatellite Stable Colorectal Carcinoma


Anti-HER2 Monoclonal Antibody/Anti-CD137 Anticalin Bispecific Fusion Protein PRS-343


Allogeneic GM-CSF-secreting Breast Cancer Vaccine SV-BR-1-GM


Anti-ICOS Agonist Monoclonal Antibody BMS-986226


Locally Advanced Epithelioid Hemangioendothelioma


Metastatic Genitourinary System Carcinoma


Steroid Refractory Graft Versus Host Disease


cEt KRAS Antisense Oligonucleotide AZD4785


Anti-NaPi2b/Auristatin F-HPA ADC XMT-1536


Advanced Lung Non-Squamous Non-Small Cell Carcinoma


Central Nervous System B-Cell Non-Hodgkin Lymphoma


Childhood Recurrent Malignant Solid Neoplasm


Childhood Refractory Malignant Solid Neoplasm


Anti-CD48/MMAE Antibody-drug Conjugate SGN-CD48A


Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma


lamivudine-tenofovir 300 mg-300 mg oral tablet


Central line-associated bloodstream infection


ST-segment elevation myocardial infarction (STEMI)


LVAD (left ventricular assist device) thrombosis


Valproate sodium 500 mg prolonged-release oral tablet


Tamsulosin hydrochloride 400 microgram prolonged-release oral capsule


Technetium diethylenetriamine pentaacetic acid


Vaso-occlusive pain episode in sickle cell disease


Alteplase 20 mg powder for solution for injection vial


Tenoxicam 20 mg powder for solution for injection vial


Macular edema of left eye due to diabetes mellitus


Erectile dysfunction due to diabetes mellitus


Clinically significant macular edema due to diabetes mellitus


cycloSPORINE ophthalmic 0.1% ophthalmic emulsion


Cysteamine Bitartrate Delayed-Release Capsules


Metastatic HER2 positive gastroesophageal junction cancer


Metastatic castration-resistant prostate cancer


Metastatic human epidermal growth factor 2 positive carcinoma of breast


Substance with receptor antagonist mechanism of action (substance)


childhood low-grade cerebellar astrocytoma


Stage IV Ovarian Germ Cell Tumor AJCC v6 and v7


Stage IV Oropharyngeal Squamous Cell Carcinoma AJCC v7


Stage IV Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7


Stage IV Hypopharyngeal Squamous Cell Carcinoma AJCC v7


Stage IV Laryngeal Squamous Cell Carcinoma AJCC v7


Stage II Esophageal Adenocarcinoma AJCC v7


Stage II Esophageal Squamous Cell Carcinoma AJCC v7


Stage III Esophageal Squamous Cell Carcinoma AJCC v7


Stage IV Lung Squamous Cell Carcinoma AJCC v7


Stage IV Esophageal Squamous Cell Carcinoma AJCC v7


Stage IV Esophageal Adenocarcinoma AJCC v7


Stage IIIA Ovarian Cancer AJCC v6 and v7


Stage IIIB Ovarian Cancer AJCC v6 and v7


malignant large intestine neoplasm stage IIa


malignant large intestine neoplasm stage IIb


malignant large intestine neoplasm stage IIIb


Substance with prostacyclin receptor agonist mechanism of action (substance)


Ovarian Cancer Stem Cell/hTERT/Survivin mRNAs-loaded Autologous Dendritic Cell Vaccine DC-006


Glucopyranosyl Lipid Adjuvant-Stable Emulsion


Vandetanib-eluting Radiopaque Bead BTG-002814


stage IVB squamous cell carcinoma of the larynx


stage IVC adenoid cystic carcinoma of the oral cavity


stage IVA mucoepidermoid carcinoma of the oral cavity


stage IVB mucoepidermoid carcinoma of the oral cavity


stage IVC mucoepidermoid carcinoma of the oral cavity


stage IVA squamous cell carcinoma of the oropharynx


stage IVB adenoid cystic carcinoma of the oral cavity


stage IVC verrucous carcinoma of the larynx


Paclitaxel Polymeric Micelle Formulation NANT-008


stage IVA adenoid cystic carcinoma of the oral cavity


stage IVA squamous cell carcinoma of the larynx


Recurrent Aggressive Non-Hodgkin Lymphoma


stage IVA verrucous carcinoma of the larynx


stage IVB squamous cell carcinoma of the oropharynx


stage IVB verrucous carcinoma of the larynx


stage IVC squamous cell carcinoma of the larynx


stage IVC squamous cell carcinoma of the oropharynx


Metastatic Squamous Cell Carcinoma of the Nasopharynx


Recurrent T Acute Lymphoblastic Leukemia


mRNA-derived Lung Cancer Vaccine BI 1361849


Refractory Head and Neck Squamous Cell Carcinoma


Cyclin-dependent Kinase 8/19 Inhibitor BCD 115


Refractory Indolent Adult Non-Hodgkin Lymphoma


Neo-multiple TAA-loaded Dendritic Cell Vaccine


Autologous Dendritic Cells Transduced with Wild-type p53 Adenovirus Vaccine


Refractory Undifferentiated Pleomorphic Sarcoma


Refractory Hypopharyngeal Squamous Cell Carcinoma


Refractory Laryngeal Squamous Cell Carcinoma


Refractory Oral Cavity Squamous Cell Carcinoma


Refractory Oropharyngeal Squamous Cell Carcinoma


Recurrent Paranasal Sinus Squamous Cell Carcinoma


Diffuse Large B-Cell Lymphoma, Not Otherwise Specified Molecular Subtypes


Recurrent Mixed Phenotype Acute Leukemia


Refractory Mixed Phenotype Acute Leukemia


Adenosine A2B Receptor Antagonist PBF-1129


WT1/PSMA/hTERT-encoding Plasmid DNA INO-5401


Polyamine Transport Inhibitor AMXT-1501 Dicaprate


Astragalus membranaceus/Angelica gigas/Trichosanthes kirilowii Maximowicz Mixed Herbal Extract SH003


Nanoparticle SN-38-encapsulated Micelle Formulation IT-141


Androgen Receptor Antagonist BAY 1161116


PEOX-based Polymer Encapsulated Paclitaxel FID-007


Refractory Chronic Myelomonocytic Leukemia


Recurrent Ovarian Endometrioid Adenocarcinoma


Refractory Ovarian Endometrioid Adenocarcinoma


Recurrent Endometrial Endometrioid Adenocarcinoma


Refractory Endometrial Endometrioid Adenocarcinoma


Recurrent Monomorphic Epitheliotropic Intestinal T-cell Lymphoma


Recurrent T-Cell Prolymphocytic Leukemia


Advanced Oropharyngeal Squamous Cell Carcinoma


Personalized Synthetic Long Peptide Vaccine


Refractory T Acute Lymphoblastic Leukemia


Metastatic Urethral Urothelial Carcinoma


Metastatic Renal Pelvis Urothelial Carcinoma


Recurrent Renal Pelvis Urothelial Carcinoma